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Early Studies Which Led to the Discovery of Natural Killer Cells 
One of the primary defenses of the host against tumor is thought 
to be the selective killing of tumor cells by tumor cell antigen- 
sensitized lymphocytes. This defense mechanism, known as cell-mediated 
immunity, was illucidated, in part, by the early studies of Mitchison 
and Dube (70,71), Southern and Dizon (109), Rosanau and Morton (95), 
Deckers et al. Wespic et al. (125), and Bard et al. (1), in which tumor- 
specific immunity could be conferred to a normal animal by transfer of 
lymphoid cells, and not sera, from tumor immune animals. Tumor-specific 
immunity to a wide variety of chemically and virally-induced cancers 
could also be induced by immunization with tumor cells. Tumor-specific 
immunity to a methylcholanthrene- induced tumor was first demonstrated “ 
by Foley (26), in which immunity was conferred by transplantation of 
growing tumor to C3H-He mice, and ligating the tumor two months later. 
Ligated tumors eventually disappeared, and the mice were immune to 
further tumor challenge by fresh tumor transplants. Sjogren et al. (107) 
reported that infection of mice with polyoma virus rendered the mice 
resistant to challenge with isogeneic, polyoma virus-induced tumors. In
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a later study (106), Sjogren reported that the resistance to polyoma 
virus-induced tumors could be accomplished by immunizing mice with 
allogeneic polyoma virus-induced tumor cells. These mice, which natu­
rally rejected the foreign tumor grafts, also developed resistance 
against syngeneic polyoma virus-induced tumor transplants. Resistance 
of these immunized mice from tumor cell challenge was an vivo mea­
surement of tumor-specific transplantation immunity. This immunity was 
thought to be associated with lymphoid cell reactions directed against 
tumor-specific transplantation antigens. An ̂  vitro method of measur­
ing this type of immunity was developed by Hellstrom (34). This tech­
nique, known as the colony inhibition assay, involved plating tumor cells 
into Petri dishes, and measuring the tumor cell colony formation, when 
cultured in the presence or absence of lymphoid cells. The general find­
ing in human and animal studies (3,12,14,45,81,82,108) was that lympho­
cytes from tumor-bearing hosts reacted much stronger against their spe­
cific tumor (more inhibition of colony formation) as compared to the 
reaction of lymphoid cells taken from normal, non-tumor bearing hosts.
In a later study, the Hellstroms et al. (35) reported that the lympho­
cytes from neuroblastoma patients reacted just as strongly against cul­
tured neuroblastoma tumor cells as did the patient's own lymphocytes.
They suggested, however, that some pre-sensitization might have taken 
place i^ utero. In a further study involving measurement of lymphocyte- 
mediated inhibition of tumor cell growth, one of the non-tumor bearing 
patient's lymphocytes demonstrated a strong inhibition of growth of a -- 
tumor cell culture (36). This natural cytotoxicity of lymphocytes from 
control animals was also observed with non-immune mouse spleen cells
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cultured with Moloney sarcoma cells (50). Takasugi et (113) also 
demonstrated the growth inhibition activity of lymphocytes from normal 
and cancer patients. In a later study (114), lymphocytes from patients 
with various cancers were tested for cytotoxicity activity against cul­
tured tumor cells. Takasugi found that the specificity of cell-mediated 
cytotoxicity was not associated with any histological type of cancer. 
More importantly, lymphocytes from some of the control patients also 
reacted against tumor cell targets. Heppner et al. (37) confirmed the 
inhibitory effects of lymphocytes from control patients on established 
cell lines, but not on short term, primary tumor cell cultures. Sendo 
et al. (101) also reported the natural occurrence of murine lymphocytes 
which were cytotoxic to BALB/c radiation-induced leukemia cells (RLÔÏ).
Svedmar and Hodes (111) reported that lymphoid cells from mice 
that were sensitized ̂  vitro, were not only cytotoxic for fibroblasts 
of the same histocompatability, but were also cytotoxic for fibroblasts 
with different histocompatability antigens. They could not attribute 
this nonspecific "killer activity" as being a general toxic effect of 
sensitized lymphocyte products, since cell-free supernatants did not 
demonstrate the toxic effect directed against these different histo- 
compatable type fibroblasts.
Keissling et al. (52) adopted the term "natural killer cell" (NK 
cell) for those naturally occurring lymphoid cells which had the capa­
bility of lysing tumor cell targets ̂  vitro. The target cell used in 
their assays was a Moloney virus-induced leukemia cell line (the murine 
cell-line, YAC-1) which had been adapted to suspension culture (11).
The assay involved labelling YAC-1 cells with ^̂ Cr (7) and mixing these
tumor cells with various numbers of effector cells (NK cells). Release 
of ^^Cr commenced in minutes, and the test was usually complete within 
4 hours at 37®C. The measure of killing was the amount of ^^Cr released 
from the YAC-1, NK cell mixture, compared to the amount of ^^Cr released 
from the YAC-1 tumor cells cultured alone. This ^^Cr release assay is 
the standard by which many investigators measure NK cell activity.
Other investigators, however, have used a post-labelling assay (21,72) 
in which NK cells and tumor target cells are allowed to react before a 
radioactive label is added. This type of assay measures the amount of 
radioactive label incorporated by tumor cells which have been exposed 
to NK cells, and compares this amount with the uptake of tumor cells 
cultured alone. This measurement is calculated using the following 
formula: Percent of Cytotoxicity =
1 minus (cpm of NK cells + tumor cells) minus (cpm of NK cells alone)
(cpm of Tumor cells cultured alone)
X 100
Characterization of the NK Cell 
Attempts to charâ ' \rize NK cells as to cell lineage has been a 
difficult problem. Early studies by Takasugi et al. (112) and Kiuchi 
and Takasugi (54) postulated a non-T, non-B cell lineage for NK cells in 
humans. Granulocytes were shown to cause detachment of adherent tumor 
target cells and were, at first, thought to be the effector cell, how­
ever, nonspecific cytotoxicity remained in the granulocyte free cell 
syspensions. Fractionation of effector cell suspensions revealed that 
the "N" cell was neither a mature T-cell nor a mature B-cell, based on 
failure to form rosettes with sheep red blood cells and the inability
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to form complement receptor rosettes. They were, however, retained on 
IgG coated columns, indicating the presence of an Fc receptor.
Most investigators ruled out the B-cell as being associated with 
NK cell activity by testing fractions of NK cells for the presence of 
complement receptors (54, 73, 126), membrane bound immunoglobulins (54, 
102), and HLAB antigen in humans (51). Recent work by Koo and Hatz- 
field (58), demonstrated that mice failed to exhibit NK cell activity 
when treated with anti-LyB-2 antiserum, a specific marker for murine 
B-cells. The evidence for a non-B lineage, however, was challenged by 
the work of Eremin (12) in which he described human NK cells as either 
being an immature precursor of the B-cell lineage, or alternatively, a 
more mature B-lymphocyte. The study was based on a sensitive, direct 
anti-globulin rosetting reaction, which detected small amounts of sur­
face immunoglobulin. However, this assay might have been detecting 
small amounts of cytophyllic antibody, rather than inherent membrane 
immunoglobulins. With the exception of the above data, most evidence 
is negative in regards to a B-cell lineage for NK cells (51,54,73,75, 
110, 125).
Recent work by Timonen e^ (115) in the human and Reynolds 
et al. (89) in the rat, has indicated that the morphology of Giemsa 
stained blood and/or spleen cell smears might be useful in the identi­
fication of natural killer cells. Timonen et al. (115) demonstrated 
that Percoll density gradient centrifugation could be used to separate 
a population of peripheral blood lymphocytes which were highly enriched 
in cells that exhibited high cytoplasmic to nuclear ratios, reniform 
nuclei, and azurophillic granules in their cytoplasms. They described
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these cells as large granular lymphocytes (LGL), and showed that they 
possessed NK cell activity. In addition, the cells were non-adherent, 
had Fc receptors, and could bind effectively to target cells. Reynolds 
et al. (89) similarly isolated and identified large granular lympho­
cytes from the peripheral blood and spleens of rats. These cells 
appeared to be similar in morphology to the large granular lymphocytes 
of humans. However, not all cells with the LGL morphology could bind 
effectively to target cells. This led to the conclusion that there 
might exist subpopulations of LGL’s with varying abilities to bind and 
eventually kill certain tumor cell targets. However, the association 
of enhanced NK cell activity with cell populations enriched for cells 
of the LGL morphology was documented in both studies. Whether or not 
the LGL "marker" is characteristic for all natural killer cells remains 
to be determined.
In most of the characterization studies, the NK cell in the human, 
mouse, and rat appeared to be non-phagocytic, ruling out a macrophage 
lineage. Recent work however, by Lohmann-Matthes and Domzig (61) has 
demonstrated a promonocyte with natural killer cell type activity 
directed against the YAC-1 cell line. These promonocytes lacked adher­
ence properties, but further differentiated into mature macrophages 
upon additional incubation at 37“C for 24 to .48 hours. They also pos­
sessed Fc receptors. Morphologically, they appeared similar to the 
large granular lymphocyte.
Recent work by Ojo ejt al. (79) however, has demonstrated that 
treatment of NK cell syspensions with complement and antiserum against 
Mph-1, an antigen known to constitute a marker for macrophages and
7
monocytes, resulted in a reduction in NK cell activity. There is not 
enough experimental evidence to rule out the promonocyte as a possible 
early precursor of NK cells. Furthermore, cell surface marker studies 
and studies of the function of promonocytes will help to determine if 
the morphological similarities exist between promonocytes and NK cells.
Early studies by West ̂  al. (126) demonstrated the presence of 
low affinity receptors for sheep red blood cells, a human T-cell marker, 
in cultures which possessed NK cell activity. Further confirmation of 
the T-cell nature came from the work of Kaplan and Callewaert (51), in 
which they demonstrated that human NK cell activity could be abrogated 
by incubation of NK cell suspension with antiserum directed against 
human T-lymphocyte antigen (anti-HTLA), but not when incubated with 
antiserum against the human B-lymphocyte antigen (anti-HLAB). In mice, 
cells with NK cell activity were found to have low density of Thy 1 
antigen, and treatment with anti-Thy 1 antiserum plus complement resulted 
in a decrease in cytotoxicity (41). In a recent study by Durdick et al. 
(19), it was demonstrated that antiserum against specific glycoproteins 
found on 30% of peripheral blood lymphocytes (non-T, non-B) could be 
used to abolish NK cell activity in the mouse. It was postulated that 
this glycoprotein (asialo-GMl) might be present as a unique marker of 
NK cells in the mouse. Studies by West et al. (126,127), Peter et al. 
(85), Pape et al. (82), and Pross and Jondal (86) have readily charac­
terized the human NK cell as also having receptors for the Fc portion of 
IgG. Studies in rats (73,75,102) and mice (2,43,79) however, have indi­
cated the presence of only a low affinity Fc receptor. The exact char­
acterization of the NK cell as to its particular cell lineage is still
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under investigation, however, recent studies (38) have indicated that 
NK cell most likely belongs to the T-cell lineage.
Augmentation of NK Cell Activity 
There are a number of conditions and treatments that have been 
shown to augment NK cell activity. Bacterial adjuvants, such as Bacil­
lus Calmette Guerin (BCG) and Corynebacterium parvum (Ĉ. parvum) have 
been demonstrated to augment NK cell activity. Wolfe et al.(128) was 
first to demonstrate that injections of viable BCG organisms into 
C57BL/6 mice caused an increase in the ability of peritoneal exudate 
cells to kill syngeneic EL-4 lymphoma cells and allogeneic P-815 masto­
cytoma target cells. He characterized the effector cells as having the 
following properties: (1) lack of adherent and phagocytic properties of 
macrophages, (2) no effect on lytic activity when treated with anti-9 
antiserum, (3) no effect on lytic activity when treated with anti-mouse 
Fab antiserum and complement, and (4) ability to kill syngeneic and 
allogeneic target cells. From these characteristics, he concluded that 
the effector cells were natural killer cells. A similar augmentation 
of NK cell activity has been reported by Tracey (116) in which intra- 
peritoneal injection of viable BGC organisms gave rise to an increase 
in the peritoneal exudate natural killer cell activity. This increase 
was shown to be mediated by macrophages and/or macrophage products, 
since in vivo treatment of mice with silica, which inactivates macro­
phages, markedly reduced the BCG-induced augmentation. Ĉ. parvum was 
shown by Oehler ̂  (76) to augment levels of NK cell activity in
strains of inbred rats with high or low levels of natural reactivity. 
Intraperitoneal (I.P.) injections of 7.0 mg per rat of Ĉ. parvum was
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sufficient to boost spleenic NK cell activity within 24 hours. Rey- 
nolds and Herbennan (88) demonstrated an ̂  vitro augmentation of rat 
NK cell activity in macrophage-depleted spleen cell cultures. Normally 
low levels of NK cell activity were boosted when cultures were incubated 
with Ĉ. parvum. Gallagher et al. (17), reported that infant mice, which 
had normally low levels of NK cell activity, aged mice, which had simi­
larly low levels of NK cell activity, and AKR mice, which had naturally 
low levels of NK cell activity throughout life, were stimulated to even 
higher levels of NK cell activity compared to normal responding control 
mice, when given I.P. injections of £. parvum. Peter et al. (84) have 
recently reported that NK cell activity of human NK cells could be aug­
mented with £. parvum. This augmentation was confined, however, to 
purified T-cell populations.
Tumor cells, themselves, also have been shown to augment NK cell 
activity. Dawkins and Shellam (15) reported that injections of a syn­
geneic gross virus-induced lymphoma into W/Fu rats increased the levels 
of NK cell activity in the spleen. These lymphoma cells (W/FuG-1) 
which were naturally susceptible to lysis by NK cells, boosted the NK 
cell activity three fold. In another study, Dawkins and Shellam (16) —
reported similar augmentations of NK cell activity with injections of 
another tumor cell line, the murine RBL-5. However, rats injected with 
the murine P-815 cell line demonstrated augmented natural killer cell 
activity to the rat W/FuG-1 line only. Bloom e^ al. (4) studied the 
effects of injection of BHK-21 or BHK-VSV tumor cells into BALB/c mice 
on the natural killer cell activity. Their findings revealed that mice 
injected with BHK-21 cells did not show any significant spontaneous NK
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cell activity compared to control mice. However, if these BHK cells 
were persistently infected with a virus such as the measles, mumps, or 
vesicular stomatitis (VSV) virus, the infected cells induced an 
increased reactivity of NK cells directed towards not only the cell 
originally injected, but also to an antigenically, unrelated, persis­
tently infected cell line such as HeLa cells infected with measles or 
mumps virus.
Viruses also have been shown to stimulate NK cell activity. Oehler 
et al. (76) demonstrated that I.P. injections of lymphocytic choriomenin­
gitis virus (LCMV) £ud the Kilham rat virus (KRV) into W/Fu rats, aug­
mented the natural killer cell activity of peritoneal exudate cells, 72 
hours following virus injection. This confirmed, for the rat, the 
earlier work of Herberman e^ al. (42) in mice, in which they demon­
strated augmentation of spleen NK cell activity by injections of a wide 
variety of viruses including Sendai, Polyoma, mouse adenovirus, LCMV, 
xenotropic type C virus, and mouse hepatitis virus. Recently, Welsh 
and Kiessling (124) reported the effects of LCMV infection of mice, and 
the possible role of the NK cell in pathogenesis of the virus. Although 
they found that injection of LCMV virus augmented NK cell activity in 
the spleen against a number of target cells, as previously reported (42, 
124), there was no apparent specificity towards LCMV virus infected 
cells. Their conclusion was that the experimental evidence failed to 
show any possible role for NK cells in the pathogenesis of the LCMV 
virus.
All of the above studies used agents which were inducers of inter­
ferons, and which have been postulated to be regulators of NK cell
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activity. Trinchieri et al. (117,118) were one of the first groups of
investigators to establish that interferon, induced by either tumor
cells or viruses, was able to enhance the NK cell activity of human
lymphocytes. Similar results were reported by Gidlund et (30), Djeu
et al. (18), and Welsh (122) in mice, utilizing a number of non-viral 
agents that have been shown to increase levels of interferon such as 
£. parvum, pyran copolymer, BCG, tilorene, and statolon. Shellam elt 
(103) reported that the i^ vitro cytotoxicity of rat NK cells was aug­
mented by the incubation of normal spleen cells with a soluble factor 
derived from a 24 hour culture of spleen cells with tumor cells. This 
factor possessed anti-viral activity, and was postulated to be a type 1 
interferon. Oehler and Herberman (74) reported that injections of 
polyinosinic-polycytidilic acid (poly IC), an interferon inducer, 
increased the NK cell activity of normal rats, and rats whose NK cell 
activity was depressed by x-irradiation or glucocorticoids. Enhance­
ment of human NK cell activity ̂  vivo by interferon has been recently 
reported by Einhorn (22) in which osteosarcoma patients, who had been 
treated with one injection of three million units of interferon, demon­
strated an increase in NK cell activity, peaking at 24 hours. The level 
of NK cell activity dropped to near normal levels by 48 hours. In an 
extended study, forty patients with a variety of cancers were tested 
before, and after treatment with interferon. With few exceptions, most 
patients exhibited an increase in NK cell activity, 24 hours following 
interferon treatment. In a similar study by Reithmuller et al. (91), 
patients with chronic aggressive hepatitis had increased NK cell activity 
following daily treatment with 6 to 10 million units of interferon.
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However, when the dosage was reduced to 2 million units per day, the 
NK cell activity decreased. This decrease was again noticeable when 
the dosage was changed to 4 million units, twice a week, which resulted 
in a decrease in NK cell activity to pre-treatment level. Pre-incubation 
of human lymphocytes vitro with interferon inducers also could enhance 
NK cell activity. Trinchieri and Santoli (118) pretreated human lympho­
cytes with 10 units of interferon and reported a two-fold increase in 
NK cell activity. However, if target cells were treated first with 
interferon, they became resistant to lysis by NK cells (117,118).
A recent study by Welsh al• (123) also reported the protection 
of normal and mouse tumor cells with fibroblast type 1 interferon from 
lysis by endogenous or virus activated mouse NK cells. Those cells that 
were not protected, were those that lacked mouse interferon receptors, 
namely F-9 teratoma cells, xenogenic Vero cells, and an interferon 
resistant L1210 line (123). This paradox might be explained by the fact 
that normal cells might have been protected from NK cell attack by low 
levels of interferon, while tumor cells or virus infected cells might 
not have had the ability to be protected by interferon, and thus be spe­
cifically lysed by interferon "activated" NK cells. On the other hand, 
Peter e^ al. (85) have reported that treatment of a human myelocytic 
leukemia cell line (K562) or an ̂  vitro derived melanoma cell line 
(IGR3) with interferon, resulted in an increase of susceptibility to 
lysis by NK cells. This difference might have been due to the specific 
variant of K562 used. The dual role of interferon as an antagonist and 
as a protagonist, in relation to NK cell activity, is not understood.
It is interesting to note that, as yet, no evidence for the protective
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effects of interferon on autochthonous tumors has been reported.
Suppression of NK Cell Activity
There are a number of agents that may suppress NK cell activity 
either directly, or indirectly by an accessory cell mechanism. The 
addition of some types of prostaglandins, especially the E series, to 
NK effector cell mixtures, has been demonstrated by Brunda et al. (5,6) 
to have a direct suppressive effect on NK cell activity. Maximum sup­
pression of NK cell activity in normal and euthymie mice occurred when 
prostaglandin was present throughout the entire assay period. Pro­
staglandin had no suppressive effect if the spleen cells were incubated 
overnight or 24 hours at 37°C. This suggested that prostaglandin recep­
tors on spleen cells were lost during the incubation period. An ̂  vivo 
correlate to prostaglandin-mediated suppression also was reported. 
Inhibitors of prostaglandin synthesis, indomethacin or aspirin, were 
injected into animals whose NK cell activity had been suppressed due to 
induction of tumors by the Moloney murine sarcoma virus. The NK cell 
activity of these treated animals was restored to near normal levels by 
either aspirin or indomethacin. The results of these studies suggested 
that prostaglandins might mediate NK cell activity vivo and vitro.
The effects of another agent, B-estradiol, on NK cell activity 
was recently reported by Seaman et al. (99,100). They demonstrated that 
the natural killer cell activity in spleens of B-estradiol treated mice 
was reduced from 45% to 10%, 6 weeks following estradiol treatment. 
Interestingly, the response of spleen cells to lipopolysaccharide (IPS), 
a B-cell mitogen, was slightly enhanced, while the response to T-cell 
mitogens such as phytohemagglutanin (PHA) and concanavalin A (con A)
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was unaltered. Estradiol did not affect natural killer activity in 
vitro, and was not due to a soluble factor or as a cellular suppressor.
It was postulated that the effects of estradiol on natural killing might 
be due to depletion of bone marrow precursors of NK cells due to osteo­
sclerosis, brought on by estradiol treatment. Further evidence for bone 
marrow destruction-induced suppression of NK cell activity was recently 
reported by Parkinson e^ al. (83). Using leukemogenic split-dose irra­
diation which reduced prothymocytes in marrow, they demonstrated sup­
pressed NK cell activity in radiation treated C57BL/6 mice. This sup­
pression was not reversed by treatment with interferon, indicating 
permanent damage to precursor NK cells.
Levels of NK cell activity have been described to be influenced by 
circadian rhythms (24), age (80), and starvation (98). A recent report 
by Zeigler e£ al. (129) has described a deficiency in natural killer 
cell activity in patients with chronic lymphocytic leukemia (CLL). They 
reported that 9 out of 10 patients with advanced disease had no detect­
able NK cell activity. Two patients, with early diagnosed disease, had 
measurable, but low NK cell activity. ^  vitro treatment of lympho­
cytes from these two patients, with human fibroblast interferon or inter­
feron inducer, poly I:C. resulted in enhancement of their NK cell activ­
ity. In vitro treatment of lymphocytes from later stage patients with, 
interferon resulted in no enhancement of their NK cell activity. The 
percentage of cells in CLL patients that resembled NK cells based on the 
presence of receptors for SRBC's and the Fc portion of IgG, was 4 times 
higher in CLL patients compared to control patients. Although the num­
ber of NK cells of CLL patients that could bind to target cells was
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equal to that of control patients, lysis of target cells by the CLL 
patients’ NK cells did not occur.
Ojo e^ al. (78) reported that £. parvum could not only augment NK 
cell activity in peritoneal exudate cells of mice, but could suppress 
NK cell activity in the spleen. This dual role depended on the route 
of injection. Intraveneous (I.V.) injection of Ĉ. parvum resulted in a 
significant decrease of natural cytotoxicity of spleen cells toward tumor 
cell targets, but no effect on the natural cytotoxicity of peritoneal 
exudate cells. Intraperitoneal injection of of £. parvum, however, 
resulted in an increase of the natural cytotoxicity of spleen cells. A 
similar result was recently reported by Lotsova (63) in which she 
described suppression of NK cell activity by I.V. injection of C. parvum 
into B6DF mice. Cell mixing experiments, however, confirmed the pres­
ence of a non-adherent suppressor cell that was activated or induced by 
iC. parvum to suppress NK cell activity of the spleen. The suppressor 
cell was resistant to various agents such as cortisone, silica, car- 
rageenan, radiation, and cytoxan. Furthermore, the suppressor cell 
effect seemed to be dependent on mature T-cell function, since con­
genitally athymic mice failed to demonstrate suppressed NK cell activity, 
following Ĉ. parvum injections. In addition, removal of T-cells by 
Sephadex G-10 or Ficoll-Hypague centrifugation resulted in release of 
the _C. parvum induced suppression. However, only a partial decrease in 
NK cell activity occurred when spleen cells were treated with anti- Thy 
1.2. This result lead to the conclusion that even though a mature T- 
cell population was strongly indicated as the suppressor cell, other 
cell populations could not be entirely eliminated.
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Macrophages have been shown to play a role in maintaining levels 
of NK cell activity in mice and rats. Oehler and Herberman (74) demon­
strated that silica, which paralyzes macrophages, resulted in the sup­
pression of NK cell activity of rat splenocytes. A suppressor cell of 
NK cell activity has been recently reported by Cudkowicz and Hochman 
(13). This cell, however, was activated by carrageenan, an anti­
macrophage agent. Spleen cells of B6C3F mice were treated with lOOg/ml 
of carrageenan for 5 days, then tested for NK cell activity against 
YAC-1 tumor cell targets. Carrageenan-treated spleen cells had no 
detectable NK cell activity. The NK cell activity was restored to 
normal levels when the carrageenan-treated spleen cells were filtered 
through Sephadex G-10. However, filtrations through glass wool or ex­
posure to carbonyl iron plus a magnetic field, failed to restore NK 
cell activity. The specific adherence to Sephadex G-10 and non­
adherence to glass wool or carbonyl iron plus a magnetic field was recon­
ciled by the fact that adherence properties might be separated from 
phagocytic properties, according to the experimental conditions used. 
Furthermore, the insensitivity of the suppressor cell activity to radi­
ation strongly suggested that the suppressor cells belonged to the 
macrophage-monocyte cell lineage. In addition, carrageenan was also 
shown to activate suppressor cells in splenocytes of athymic mice, indi­
cating that the cells could not belong to the post-thymic pool of splenic 
T-lymphocytes. A final interesting result of this study was that super­
natants from the carrageenan-treated splenocytes were able to suppress 
NK cell activity, again suggesting a macrophage origin for these sup­
pressor cells. Santoni et (97) have presented further evidence of
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the macrophage as being a regulator cell for the inhibition, as well as 
augmentation of NK cell activity. They reported that both agents, pyran 
copolymer, and adriamycin were able to either augment or suppress NK 
cell activity, depending on the dose or the route of injection. In 
pyran suppressed mice, the suppressor cell could be removed by carbonyl 
iron plus a magnetic field, was not inactivated by 2000 R of radiation, 
nor did it possess phygocytic properties. Similar results were obtained 
from the adriamcin-treated mice. Their conclusion was that the macro­
phage was the regulator of NK cell activity. Even though there is sub­
stantial evidence for the presence of an activated suppressor cell in 
treated mice, there is no evidence that naturally low responding strains 
of mice are deficient in NK cell activity, due the presence of naturally 
occurring suppressor cells (27).
Role of NK Cells In Vivo 
There have been a number of studies which have indicated that NK 
cells might be important as anti-tumor effector cells. Herberman and 
Holden (40) and Keissling e^ al. (52) have observed that tumors that 
were sensitive to NK cell activity in vitro grew poorly in nude mice. 
Furthermore, tumor cells were more difficult to transplant into 5 to 10 
week-old m:‘.ce, the age that correlates with peak NK cell activity, com­
pared to mice whose activity had declined with age (39). In addition, 
Riccardi et (90) reported that lethally irradiated mice could reject 
normal or drug-treated lymphoma cells. Haller al. (33) demonstrated 
that one could transfer bone marrow precursor cells from high or low 
responding NK strains to lethally irradiated NK strains and produce 
mice whose NK cell activity and resistance to tumor was that of the
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donor. An interesting note in these studies was that the ultimate test 
for jüi vivo NK cell activity was measured by resistance to a small 
innocula of tumor cells. This suggested that NK cells might play a 
role in the early stages of tumor cell growth (40). There are no pres­
ent studies which have defined an ̂  vivo role of NK cell activity in 
the development of spontaneous or chemically-induced tumors, or in com­
bination with promoters. However, some evidence as to the effects of 
carcinogens or promoters on NK cell activity has recently been reported 
(20,31).
Erlich e^ al. (20) have recently obtained data on the effects of 
two chemical carcinogens, 7,12-dimethlbenz(a)anthracene (DMBA) and ure­
thane, on the NK cell activity in mice. They found that the NK cell 
activity was suppressed for up to 6 weeks following DMBA administration. 
In addition, the number of cells per spleen was also decreased. In 
contrast, however, urethane treatment caused an increase in the NK cell 
activity of these mice. These apparent discrepancies, however, empha­
sized that carcinogens could produce early changes in NK cell activity, 
which might be important in early tumor development. The tumor promoter, 
phorbol-12myristate-13-acetate (PMA) has been recently shown by Goldfarb 
and Herberman (31) to inhibit mouse and human NK cell activity. They 
postulated that the ability of the PMA to inhibit NK cell activity might 
be related to its tumor promoting ability. The area of carcinogenesis 
and tumor promoting effects on NK cell activity, however, is not well 
known.
DMBA has been shown to be an effectx.e inducer of mammary gland 
adenocarcinomas in the rat, especially by combining carcinogen treatment
19
with a diet of high, polyunsaturated fats (8,9,10,53). Since fats and 
fatty acids have been shown to be suppressive to the immune response 
(65,68), the combination of DMBA and polyunsaturated fat effects on 
immune function were recently examined by Kollmorgen et al. (57). They 
reported that polyunsaturated fats and DMBA were suppressive to the 
immune system, as measured by lectin-induced blastogenesis. Further, 
tumor incidence was highest in rats on polyunsaturated fat diets whose 
lymphocyte responses were low compared to the lower tumor incidence of 
rats on low fat diets, and whose lymphocytes responses were high. In 
another study, Kollmorgan e^ (55) reported that the methanol extrac­
tion residue of Bacillus-Calmette-Guerin (MER) protected rats against 
DMBA-induced mammary carcinomas when given before carcinogen administra­
tion. They postulated that the macrophage might play a pivotal role in 
directing lymphoid cell responses against tumor cells, and that this 
direction might be influenced by diet-related inhibitory factors via 
serum constituents. Other investigators have reported the effects of 
dietary polyunsaturated fats on immune functions and tumor promotion. 
Hillyard and Abraham (44) reported that dietary polyunsaturated fat 
promoted the growth of six transplantable rat and mouse mammary adeno­
carcinomas. They also reported that treatment of mice with inhibitors 
of prostaglandin synthetase prevented the growth-promoting effect of 
polyunsaturated fats. Their conclusion was that the growth enhancing 
effect of polyunsaturated fats might be mediated through the cellular 
immune system, with the involvement of prostaglandins in the regulatory 
process. Studies by Carroll and Khor (8) first reported that rats 
changed, from a low fat diet to a high fat diet at the time of exposure
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to DMBA, had the same tumor incidence compared to rats fed a high fat 
diet both before, and after exposure to DMBA. Conversely, tumor inci­
dence in rats changed to the low fat diet at the time of carcinogen 
administration was not different compared to rats maintained on the low 
fat diet continuously. Ip (47) reported that feeding of a 20% poly­
unsaturated fat diet to older rats (150 days) which were more resistant 
to DMBA tumorigenesis than younger rats (50 days old), resulted in an 
increased incidence of tumors in the resistant rats. He also reported 
that rats which were maintained on high fat diets continuously, or 
were changed from a low fat diet to a high fat diet after carcinogen 
administration, had the highest incidence of tumors compared to rats 
fed low fat diets continuously, or changed from high fat to low fat 
diets, following carcinogen administration. He concluded that the diet 
fed after carcinogen might influence the promotional phase of carcin­
ogenesis. In another study (48), Ip reported that transplantation of 
mammary gland explants, that had been exposed to DMBA in vitro, trans­
planted with a higher incidence into rats on high fat diets than on 
low fat diets.
Another dietary effect upon the induction of tumors was recently 
reported by Lombardi et al. (62) and Shinozuka et al. (104). They 
reported that rats fed choline deficient diets developed fewer tumors 
when exposed to 2-acetylaminofluorene or ethionine. Rats exposed to 
these two carcinogens and fed choline supplemented diets did not develop 
tumors. However, experiments were not continued long enough to deter­
mine if. choline was acting in a protective manner, or if it was only  --
delaying tumor formation.
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One of the interrelationships between dietary fat, carcinogen, 
and choline definiency is that all of these factors have been shown to 
play an important role in the etiology of neoplastic disease. Although 
some of these factors have been demonstrated to cause suppression of 
various in vitro and in vivo immune responses, the relationship between 
immune dysfunction and the development of neoplasia influenced by these 
factors is not well known. If natural killer cells are important in 
the host's immune surveillence system, then it might be predicted that 
immune dysfunction caused by dietary and carcinogenic influences 
might be reflected in altered activity of natural killer cells.
Our previous studies have shown that rats maintained on high fat 
diets (20% corn oil) and given DMBA, have a greater incidence of mam­
mary tumors, and a concurrent suppressed lymphocyte response to mitogens, 
compared to rats on low fat diets (2% linoleic acid) and similarly given 
DMBA. The present study was designed to develop techniques for the 
isolation and partial characterization of rat natural killer cells, and 
to study the relationship between the high fat dietary state, and sup­
pressed levels of natural killer cell activity directed towards a rela­
tively sensitive tumor target cell (YAC-1), and- a target cell that was 
originally derived from rats fed high fat diets, and given DMBA. 
Furthermore, our assay for natural killer cell activity was designed to 
use low effector to target cell ratios, 20 hour incubation periods, and
3measurement of inhibition of incorporation of H-thymidine by target 
cells cultured with effector (NK) cell populations. This assay was 
used, rather than the standard 4 hour, ^^Cr release assay, using low 
effector to target cell ratios. Our assay was designed to study ̂
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vitro conditions of natural killer cell activity that might reflect 
conditions found ̂  vivo, and therefore, possibly correlate levels of 
natural killer cell activity with dietary states which have been demon­
strated to influence the development of DMBA-induced tumors.
CHAPTER II 
MATERIALS AND METHODS 
Animals
Female, albino, outbred, Sprague-Dawley rats were used for these 
studies. Weanlings (21 days old) were obtained from Charles Rivers 
Breeders (Portage, Mich.) which had been certified clean of SDA, Sendai, 
and Kilham rat viruses. Rats were then placed and maintained on one of 
four diets (ICN Pharmaceutical, Inc., Life Sciences Group, Cleveland, 
Ohio) as outlined in Table 1. Diets were fed ad libitum and were not 
isocaloric. However, based on caloric density and the amount of diet
consumed per day, the daily caloric intake for all groups was similar.
Previous studies (53) indicated that quantitative differences in dietary
fat did not influence growth rate.
Exposure to Carcinogen 
One-half of the rats in each dietary group was given carcinogen, 
while the other half of the rats served as control. Rats were given 
10 mg of 7,12-dimethylbenz(a) anthracene (DMBA) (Sigma Chemical Co.,
St. Louis, Mo.) in 1.0 ml of stripped corn oil, with a stomach tube at 
50 days of age.
Spleen Cell Preparation 
Two rats from each dietary group, with and without DMBA, were 
killed with nitrogen on a weekly basis. Spleens were excised, weighed,
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and transferred to a tissue homogenizer (Kontes Glass Co., Vineland, 
N.J.). Fifteen ml of RPMI 1640 media, supplemented with 5 ml of Peni­
cillin (5,000 units/ml) and Streptomycin (5,000 mcg/ml) (Grand Island 
Biological, Grand Island, N.Y.) was added, and the spleen gently homog­
enized to obtain a single cell suspension. This spleen cell suspension 
was centrifuged for 10 minutes at 550 g. The supernatant was decanted, 
and the resulting cell pellet resuspended in 11 ml of RPMI 1640 with 
antibiotics. These spleen cell suspensions were placed on ice for 10 
minutes to allow settling of cellular debris and connective tissue.
The supernatant containing the spleen cells was removed to another tube, 
and the cells counted with a Coulter Counter (Model ZBI, Coulter Elec­
tronics, Hileah, Fla.). The cell concentration was adjusted to 1.0 x 10̂  
cells/ml by dilution with RPMI 1640 media plus antibiotics.
Removal of Adherent Cells and Macrophages 
Partial purification of lymphocyte suspensions was carried out 
according to modified techniques of Garvin (29) and Rabinowitz (87).
Ten ml plastic pipettes (Falcon Products, Cockeyville, Md.) were filled 
with an 8 ml volume of plastic beads (Separ-Aid, J.T. Baker, Bethleham, 
Penn.). The columns were washed with 15 ml of RPMI 1640 with antibiotics 
and supplemented with 10% horse serum (Colorado Serum Co., Denver, Co.) 
at 37“C. The columns were loaded with 3 ml of spleen cells at a con­
centration of 2.0 X 10̂  cells/ml and stoppered immediately with plastic 
caps. The columns were incubated for 30 minutes at 37®C in a 10% COg 
incubator, to allow adherent cells (macrophages) to attach. The stoppers 
were removed, and the resulting enriched lymphocyte suspension was col­
lected in conical centrifuge tubes (Corning, Corning, N.Y.). Any
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remaining non-adherent cells were collected by washing the columns with 
5 ml of RPMI 1640 media with 10% horse serum. The resulting cell 
suspension was washed twice with RPMI 1640 without serum, and resus­
pended in 1.0 ml of RPMI 1640 media with antibiotics and 10% fetal calf 
serum (K.C. Biologicals, Lenexa, Ks.). The cell suspension was counted 
with a Coulter Counter, and the cell concentration adjusted to 3.0 x 10̂  
cells/ml by diluting with RPMI 1640 with antibiotics and 10% fetal calf 
serum. Three columns were routinely used for each spleen, and 50% to 
70% of the loaded cells were recovered. Non-adherent and whole spleen 
cell populations were stained for nonspecific esterase according to the 
method of Koski (57), (See Appendix, Table 1).
Cell Separation by Density 
Cell suspensions were separated using Percoll discontinuous gradi­
ent centrifugation (Pharmacia, Pitscataway, N.Y.). Percoll was made 
isoosmotic by diluting 9 parts of Percoll with 1 part of lOX phosphate 
buffered saline. This solution was referred to as stock Percoll. 
Different percentages of Percoll solutions were made by diluting stock 
Percoll with RPMI 1640 with antibiotics and 10% fetal calf serum. The 
resulting percentage Percoll solutions were used to construct discon­
tinuous gradients by carefully layering 2 ml of each percent Percoll 
solution, starting with the highest percentage at the bottom of the tube 
and continuing with each successive lower percentage Percoll solution. 
The constructed gradients consisted of Percoll percentage solutions of 
26% or 40% at the top, followed by 45%, 50%, 55%, 60% and 65%. The 
density range of the gradient was determined to be from 1.048 g/ml to
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1.086, as determined by density marker beads (Pharmacia, Pitscataway, 
N.J.), (See Appendix, Figure 1). One ml of the lymphocyte suspension 
at a concentration of 3.0 x 10̂  cells/ml was carefully layered onto the 
top layer of each gradient. The gradients were placed in a refrigerated 
centrifuge (Damon/IEC, Needham Hts., Mass.) and spun at 550 g at I5“C 
for 30 minutes. Bands of cells appeared at each Percoll density inter­
face, and were collected by aspirating each Percoll layer, starting at 
the top of the gradient. Cells that passed through the gradient and 
formed a pellet at the bottom of the tube also were collected. In 
preliminary studies, lymphocytes from each interface, with the exception 
of the pelleted cells, were tested for their ability to inhibit H- 
thymdine Incorporation into YA.C-1 and RgTg tumor cells, at various ' 
effector to target cell ratios, and at different incubation times (See 
Appendix, Figures 2, 3, and 4). For the main study, gradients were 
constructed with 4 ml of the 26% Percoll solution at the top of the tube 
to serve as a cell cushion, followed by 2 ml of the 50%, 55%, 60%, and 
65% Percoll solutions. Each band or combination of bands was collected 
by aspirating each Percoll layer, starting at the top of'the gradient.
The cell suspensions were counted, and the total recovery and percentage 
of each cell band contributing to the total number of cells recovered 
from the gradients was calculated. Cells from the 26% and 50% interfaces 
were combined and tested for NK cell activity. Cells from the 55% and 60% 
interfaces were tested separately, and as a combination. Cells from the 
65% interface were also tested for NK cell activity (See Appendix,
Figures 2, 3, and 4).
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Analysis of Cell Morphology 
Spleen cell populations from each density fraction of the Percoll 
gradients were adjusted to 1 x 10̂  cells/ml with RPMI 1640 media with 
antibiotics and 10% fetal calf serum. One ml of each cell suspension 
was centrifuged onto glass slides for 10 minutes at 900 rpm, using a 
Cytospin centrifuge (Shandon Southern Instrument Inc., Sewickey, Penn.). 
The preparations were air dried and then fixed for 10 minutes in cold 
absolute methanol. The slides were stained for 20 minutes with Giemsa 
stain (Harleco, Gibbstown, N.J.). Slides were examined by oil immersion 
microscopy, and photographed using an Olympus Vanox microscope with an 
Olympus PM-lOA photographic system (Olympus, Inc., Tokyo, Japan).
Tumor Cell Targets 
Tumor cells used as targets for the natural killer cell assay were 
the YAC-1, (a Moloney virus-induced murine lymphoma) and the RgTg (orig­
inally obtained from a rat mammary adenocarcinoma, induced by DMBA while 
the rat was maintained on a high fat diet). The YAC-1 lymphoma (11) was 
kindly supplied by Dr. Ronald B. Herberman, NIH, Bethesda, Md., through 
Dr. Juneann Murphy, Department of Botany and Microbiology, University of 
Oklahoma, Norman, Oklahoma. The R^Tg cell line was isolated and provided 
by Dr. Pal-Min Tseng Loh, University of Iowa, Iowa City, Iowa. The YAC-1 
cell line was maintained as a suspension culture in RPMI 1640, supple­
mented with 10% fetal calf serum, penicillin, and streptomycin. Growth 
studies indicated that the YAC-1 cells had a doubling time of approxi­
mately 24 hours, between cell concentrations of 5 x 10̂  to 2 x 10̂  cellsg
per ml. Cell densities of 3 x 10 cells/ml or higher resulted in a
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slower growth rates, and were not used at this concentration as targets 
in the natural killer cell assays. Viability of log phase cells as 
measured by Trypan blue exclusion was consistently greater than 97%.
An initial cell density of 5 x 10̂  cells/ml was selected as the con­
centration to be used for the target cells to ensure use of tumor cell 
targets that were in logarithmic growth in day to day assays. Also, 
this number of tumor cells could be accurately counted with the Coulter 
Counter.
The ^2^2 cell line was maintained as a monolayer culture in
T-75 tissue culture flasks (Falcon Products, Cockeysville, Md.) in 
Medium 199, supplemented with 10% fetal calf serum, penicillin, and 
streptomycin. These tumor cells had a doubling time of approximately 
24 hours. Cell densities of 3 x 10̂  cells/ml represented a cell mono­
layer that was approximately 30% confluent in tissue culture flasks and 
microtiter test plate wells (Falcon Products, Cockeysville, Md.). Cell 
densities of 1 x 10̂  cells/ml or greater represented 100% confluency.
To ensure that the RgTg tumor cells were provided with optimal growth 
conditions for a 24 hour incubation period, stock cultures were ini­
tiated with 5 X 10̂  cells/ml, and were used 24 hours later in the 
natural killer cell assay. These cells had a consistant viability of 
between 96% and 100%, as determined by Trypan blue exclusion.
Determination of Killing Ability of NK Cells Based on Cell Viability
Spleen cells obtained from the natural killer cell enriched frac­
tion of the Percoll gradients were cultured with YAC-1 tumor cells as 
outlined in the assay for natural killer cell activity. At the end of 
the incubation period, the cultures containing the NK cells and YAC-1
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tumor cells were collected and stained with a 0.5% solution of Trypan 
blue. Wet preparations were examined under medium power (450x) and 
photographed using an Olympus Vanox microscope with a Nomarski differ­
ential interference contrast attachment and an Olympus PM-lOA photo­
graphic system (Olympus, Inc., Tokyo, Japan). Killing ability of the 
NK cells against the R^Tg tumor cell line was not measured, since differ­
entiation between RgTg tumor cells and rat NK cells by their relative 
size was not possible.
3Natural Killer Cell Assay Based on H-thymidine Incorporation
In the natural killer cell assay, YAC-1 target cells at a con­
centration of 5 X 10̂  cells/ml were cultured alone, or in combination 
with various concentrations of Percoll separated or unseparated spleen 
cells. A volume of 0.1 ml of YAC-1 tumor cells (1 x 10̂  cells/ml) was 
added to triplicate wells of a microtiter test plate. To these wells 
was added a 0.1 ml volume of spleen cells obtained from the different 
density fractions of the Percoll gradients or from the unfractionated 
spleen cell populations. The numbers of spleen cells added to tumor 
cells were 0.1 ml volumes of cells at a concentration of 16 x 10̂  cells/ 
ml. 8 X 10̂  cells/ml, 4 x 10̂  cells/ml, and 2 x 10̂  cells/ml. The num­
bers of spleen cells cultured with tumor cells were expressed as the 
ratio of effector (spleen) cells to target (tumor) cells. Effector 
cells and target cells cultured alone served as controls. Cells were 
cultured for time periods of 3, 5, or 16 hours, followed by the addition 
of .025 ml of (6-^H)-thymidine (l.OyCi/well, spec, activ.>15 Ci/mmol,
New England Nuclear, Boston, Mass.). Following an additional 3.5 hour
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incubation, cells were harvested onto glass fiber filter strips (What­
man, Clifton, N.J.) using a Multiple Automated Sample Harvester (MASH II) 
(M.A. Bioproducts, Walkersville, Md.). The filter strips were dried, 
and the cells transferred to scintillation vials to which 10.0 ml of 
scintillation fluid was added (Fisher Scientific, Pittsburg, Penn.).
3The amount of H-thymidine incorporated into the cells was determined 
by liquid scintillation counting using a Beckman LS-3155T liquid scintil­
lation counter (Beckman Instruments, Fullerton, Calif.). Natural killer 
cell activity was expressed as the inhibitory activity of spleen cells
3cultured with YAC-1 tumor cells as compared to the H-thymidine incorp­
oration of the YAC-1 tumor cells cultured along (control). This was 
calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of Spleen Cells minus (cpm of Spleen cells
+ YAC-1 cells)______________ cultured alone) ^
cpm of YAC-1 cells cultured alone)
For the natural killer cell assay using the YAC-1 tumor cells as targets, 
the following optimal conditions were used as the standard for the day 
to day assays. Spleen cell populations used for the Percoll density 
gradient centrifugation were obtained from plastic beaded column separ­
ated cells. Effector to target cell ratios were 4:1. Incubation time
3was 16 hours, followed by an additional 3.5 hour incubation with H-
thymidine (see Appendix, Figures 2 and 3).
The natural killer cell assay using the RgTg cell line was set up
in a similar manner, with the exception of using an effector to target
cell ratio of 13:1. In addition, effector cells were removed before 
3the H-thymidine label was added. After the 3.5 hour incubation, the
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RgTg target cells were removed by a 10 minute incubation with trypsin,
and EDTA (K.C. Biologicals, Lenexa, Ks.). The cells were harvested,
and the radioactive label incorporation determined (see Appendix,
Figure 4). Natural killer cell activity was expressed as inhibitory
activity of spleen cells cultured with RgTg tumor cells as compared to 
3the H-thymidine incorporation of the RgTg tumor cells cultured alone 
(control). This was calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of RgTg tumor cells cultured with spleen cells) 




Morphology of Percoll Separated Spleen Cells 
Plate la shows the spleen cell preparation before separation by 
Percoll density gradients. A lymphocyte having a large cytoplasmic to 
nuclear ratio, a reniform nucleus, and azurophillic granules in the 
cytoplasm can be seen in the middle of the field. Various other cell 
types such as polymorphonuclear leukocytes, macrophages, and small lym­
phocytes can also be seen.
Plate lb shows the spleen cell preparation collected from the 55% 
and 60% fractions of the Percoll gradients. Numerous lymphocytes with 
large cytoplasmic to nuclear ratios, reniform nuclei, and azurophillic 
granules in their cytoplasms can be seen. Other cells of the same size, 
but lacking granules, can also be seen.
Plate Ic shows the spleen cell preparation collected from the 65% 
fractions of the Percoll gradients. These cells exhibit the morphology 
of medium to small lymphocytes, with no indication of granules in their 
cytoplasms, reniform nuclei, or large cytoplasmic to nuclear ratios.
Plate Id shows a preparation of lymphocytes collected from the 55% 
and 60% fractions of the Percoll gradients which have been cultured with 
YAC-1 tumor cells. One YAC-1 tumor cell is shown surrounded by three 
natural killer cells. Trypan blue staining revealed that the YAC-1 
tumor cell was non-viable, while the natural killer cells were viable.
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Also in the field is shown another YAC-1 tumor cell that has no natural 
killer cells associated with it. Trypan blue staining revealed it to 
be viable. These results were from only one experiment, and therefore 
the numbers of NK cells that bound and killed YAC-1 tumor cells were 
not quantitated.
3Inhibition of Incorporation of H-thymidine into YAC-1 Tumor Cells Cul­
tured with Spleen Cells from Rats Fed Low Fat or High Fat Diets
3The ability of spleen cells to inhibit H-thymidine incorporation
3into YAC-1 tumor cells was expressed as a percentage of the H-thymidine
incorporation of the YAC-1 tumor cells in the presence of spleen cells,
3compared to the H-thymidine incorporation of YAC-1 tumor cells cultured 
alone (control).
Figure 1 compares the inhibitory activity of Percoll separated and 
unseparated spleen cells, as a function of age, in rats maintained on
3a low fat diet. Inhibition of H-thymidine incorporation was high on 
day 48 (10% incorporation) when tumor cells were cultured with the NK 
fraction. A decrease in inhibitory activity wa? observed on day 55. 
Thereafter, the inhibitory activity increased, and, from day 69 to day
390, the H-thymidine incorporation did not exceed 9% of control values. 
The lesser activity of the 65% fraction and the unseparated spleen cell 
populations followed the same general pattern, with maximum inhibition 
on days 60 through 76. However, this inhibitory activity decreased 
again on day 83. This "cyclic" inhibitory activity was observed in the 
65% fraction and unseparated spleen cell populations, but not in the 
NK cell fraction.
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Figure 2 compares the inhibitory activity of the three spleen 
cell populations from rats maintained on a high fat diet. Inhibition
3of H-thymidine incorporation into YAC-1 tumor cells by the NK cell 
fraction was low on days 50 and 57 (48% and 50% incorporation, respec­
tively) . A rapid increase in inhibitory activity was observed on day 
64 (11% incorporation). Following this, there was a gradual decrease 
in inhibitory activity through day 78 (45% incorporation). Thereafter, 
inhibitory activity increased to a maximum value of 9% incorporation by 
day 92. The lesser inhibitory activity of the 65% fraction and unsep­
arated spleen cell populations followed the same general pattern as the 
NK cell fraction, with maximum activity on day 64 (15% and 44% incorpor­
ation, respectively). However, the maximum decrease in inhibitory 
activity of the 65% fraction and unseparated spleen cell populations 
occurred earlier (day 71) compared to the decrease shown by the NK cell 
fraction. Nonetheless, "cyclic" inhibitory activity was observed in 
all three spleen cell populations.
Figure 3 compares the inhibitory activity of only the NK cell frac­
tion from rats fed a low fat diet, to rats fed a high fat diet. Inhib­
itory activity of the NK cell fraction from rats on a low fat diet was 
significantly higher compared to the inhibitory activity of the NK cell 
fraction from rats fed a high fat diet, on days 48-50, p = .0001; days
69-71, p = .0018, days 76-78, p = .0001, and days 83-85, p. = .0260.
The results from Figures 1, 2, and 3 indicated that; (a) rats fed low 
fat diets generally had higher levels of inhibitory activity associated 
with their NK cell fraction compared to lower levels and "cyclic" inhib­
itory activity of their 65% and unseparated spleen cell populations.
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(b) rats fed high fat diets also had high levels of inhibitory activity 
associated with their NK cell fraction compared to their 65% and un­
separated spleen cell populations, however, all three spleen cell pop­
ulations demonstrated "cyclic" levels of inhibitory activity and (c) the 
inhibitory activity of the NK cell fraction from rats on the low fat 
diet was generally higher compared with the inhibitory activity of the 
NK cell fraction from rats on a high fat diet. This difference in in­
hibitory activity was due to the "cyclic" behavior of the NK cell frac­
tion of rats on the high fat diet.
3Inhibition of Incorporation of H-thymidine into YAC-1 Tumor Cells Cul­
tured with Spleen Cells from Rats Fed Low or High Fat Diets and
Given DMBA on Day 50
Figure 4 compares the inhibitory activity of the three spleen cell
populations from rats fed a low fat diet and given DMBA on day 50. In- 
3hibition of H-thymidine incorporation into YAC-1 tumor cells by the NK 
cell fraction was relatively low on day 55 (35% incorporation) and grad­
ually increased thereafter, reaching a maximum between days 69 to 76, as 
measured by only 8% incorporation. This inhibitory activity gradually 
decreased to its initial level by day 92. The lesser inhibitory activity 
of the 65% fraction and unseparated spleen cells demonstrated the same 
increasing trend towards maximum inhibitory activity on day 69 (25% and 
30% incorporation, respectively). However, on days 76 and 83, inhibitory 
activity of the 65% and unseparated spleen cells returned to their ini­
tial levels. Inhibitory activity of both populations increased on day 
92. This "cyclic" inhibitory activity of the 65% fraction and the un­
separated spleen cell populations was not observed for the NK cell frac­
tion.
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Figure 5 compares the inhibitory activity of the three spleen 
cell populations from rats fed a high fat diet, and given DMBA on day 
jO. Inhibitory activity of the NK cell fraction was low on day 57, as 
measured by .63% incorporation by YAC-1 targets. The inhibitory activity 
increased by day 64 (15% incorporation. By day 17, however, the inhib­
itory activity had decreased slightly to 20% incorporation. On day 78, 
the inhibitory activity increased to a maximum value of 4% incorporation. 
On day 85, there was another decrease in inhibitory activity (52% incor­
poration), followed by another increase on day 92 (11% incorporation).
The 65% fraction and the unseparated spleen cell populations followed 
the same general "cyclic" inhibitory pattern, with maximum values of 
inhibitory activity on day 64 (11% and 22% incorporation, respectively). 
The inhibitory activity of both spleen cell populations gradually de­
creased over the next three weeks over a range or 40% to 70% incorpora­
tion. A slight increase in inhibitory activity in both fractions was 
observed on day 92.
Figure 5 compares the inhibitory activity of only the NK cell frac­
tions of rats fed a low fat diet and given DMBA, to rats fed a high fat 
diet and given DMBA. Inhibitory activity of the NK cell fraction from 
rats fed a low fat diet and given DMBA was significantly higher compared 
to the inhibitory activity of the NK cell fraction from rats fed a high 
fat diet and given DMBA, on days 55-57, p = .0474 and on days 83-83, 
p = .0004. The results from Figures 4, 5, and 6 indicated that; (a) rats 
fed low fat diets and given DMBA had generally higher levels of inhib­
itory activity associated with their NK cell fraction compared to the 
"cyclic" behavior of their 65% fraction and unseparated spleen cell
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populations, (b) rats fed high fat diets and given DMBA had higher 
levels of inhibitory activity associated with their NK cell fraction 
compared to their 65% fraction and unseparated spleen cell populations, 
however, all three spleen cell populations demonstrated "cyclic" levels 
of inhibitory activity and, (c) the inhibitory activity of the NK cell 
fractions from rats fed a low fat diet, and given DMBA was greater, at 
only two time points, compared to the inhibitory activity of the NK cell 
fraction from rats fed a high fat diet, and given DMBA. This difference 
was due to the "cyclic" behavior of the NK cell fraction from rats fed 
a high fat diet, and given DMBA.
3Inhibition of Incorporation of H-thymidine by YAC-1 Tumor Cells 
Cultured with Spleen Cells from Rats Fed Low Fat or 
High Fat Diets Deficient in Choline
Figure 7 compares the inhibitory activity of the three spleen cell 
populations from rats fed a low fat, choline deficient diet. Inhibition
3of H-thymidine incorporation into YAC-1 tumor cells by the NK cell frac­
tion was low on day 49 (75% incorporation). This inhibitory activity, 
however, increased to a high level (5% incorporation) by day 70, and 
maintained a level that never exceeded 8% incorporation through day 84.
On day 19, however, inhibitory activity decreased to 45% incorporation. 
The inhibitory activity of the 65% fraction and the unseparated spleen 
cell populations followed the same general initial pattern, with maximum 
inhibitory activity demonstrated on day 70. However, both of these 
spleen cell populations showed minimal activity, thereafter.
Figure 8 compares the inhibitory activity of the three spleen cell 
populations from animals fed a high fat, choline deficient diet. The
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inhibitory activity of the NK cell fraction was high on day 51 (11% in­
corporation), and decreased to 29% incorporation by day 86. The lesser 
inhibitory activity of the 65% fractions followed the same type of 
"cyclic" pattern, while the unseparated spleen cell populations, after 
showing a slight decrease, maintained a relatively constant level of 
inhibitory activity, ranging from 55% to 65% incorporation.
Figure 9 compares the inhibitory activity of only the NK cell 
fractions from rats fed a low fat, choline deficient diet to rats fed 
a high fat, choline deficient diet. Significant differences were evi­
dent at only the very early (days 40-51, p = .0001) or late (days 84-84, 
p = .0391 and days 91-93, p = .0001) time points. The results from 
Figures 7, 8, and 9 indicated that; (a) rats fed low fat, choline defi­
cient diets had generally higher levels of inhibitory activity associ­
ated with their NK cell fraction compared to the "cyclic" inhibitory 
activity of their 65% fraction and unseparated spleen cell populations, 
(b) rats fed high fat, choline deficient diets generally had higher 
levels of inhibitory activity associated with their NK cell fraction com­
pared to their 65% fraction and unseparated spleen cell populations, 
however, this "cyclic" inhibitory activity was present only in the NK 
cell fraction and the 65% fraction, and (c) there was little difference 
in the inhibitory activity of the NK cell fractions from rats low fat, 
choline deficient diets to rats fed high fat, choline deficient diets. 
This was due to the fact that the NK cell fraction from rats fed high 
fat, choline deficient diets, did not demonstrate substantial losses in 
"cyclic inhibitory activity, over a majority of the time points tested, 
compared to the inhibitory activity of the NK cell fraction from rats
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fed low fat, choline deficient diets.
3Inhibition of Incorporation of H-thymidine into YAC-1 Tumor Cells 
Cultured with Spleen Cells from Rats Fed Low Fat or High Fat
Diets, Deficient in Choline, and Given DMBA on Day 50
Figure 10 compares the inhibitory activity of the three spleen 
cell populations from rats maintained on a low fat, choline deficient
3diet, and given DMBA on day 50. Inhibition of H-thymidine incorporation 
into YAC-1 tumor cells by the NK cell fraction increased from 22% incor­
poration on day 56, to less than 1% incorporation by day 70. This level
was maintained at a value of no greater than 20% incorporation through 
day 84. On day 19, however, the inhibitory activity decreased to 58% 
incorporation. Both the 65% fraction and the unseparated cell popula­
tions followed the same general increasing trend, with maximum inhibitory 
activity on day 70 (6% and 25% incorporation, respectively). This inhib­
itory activity, however, decreased on day 77, increased on day 84, and 
decreased on day 91. This "cyclic" inhibitory activity of the 65% and 
unseparated spleen cell populations was not evident in the NK cell 
fraction.
Figure 11 compares the inhibitory activity of the three spleen 
cell populations from rats fed a high fat, choline deficient diet, and 
given DMBA on day 50. On day 58, the NK cell fraction demonstrated lit­
tle inhibitory activity (95% incorporation). This was followed by a slow 
increase in inhibitory activity over a three week period, reaching a 
peak of inhibitory activity of 20% incorporation by day 79. This was 
followed by a decrease to 41% incorporation on day 86, and an increase
to a maximum inhibitory value of 5% incorporation by day 93. The lesser
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inhibitory activity of the 65% fraction and the unseparated spleen cell 
populations followed the same general type of slow increase, reaching 
a peak of inhibitory activity of 20% incorporation by day 79. This was 
followed by a decrease to 41% incorporation on day 86, and an increase 
to a maximum inhibitory activity value of 5% incorporation by day 93.
The lesser inhibitory activity of the 65% fraction and the unseparated 
spleen cell populations followed the same type of slow increase to maxi­
mum inhibitory activity between days 72 and 79, and a slight decrease 
between days 79 and 86, followed by a slight increase in inhibitory 
activity by day 93.
Figure 12 compares the inhibitory activity of only the NK cell 
fractions from rats fed a low fat, choline deficient diet, and given 
DMBA on day 50, to the inhibitory activity from rats fed a high fat, 
choline deficient diet, and given DMBA on day 50. The inhibitory activ­
ity of the NK cell fraction from rats fed the low fat, choline deficient 
diet and given DMBA was significantly higher, compared to the inhibitory 
activity from rats fed the high fat,choline deficient diet, and given 
DMBA on day 50, on days 56-58, p = .0001; days 63-65, p = .0001; days
70-72, p = .0001; and days 84-86, p = .0003. The results from Figures 
10, 11, and 12 indicated that; (a) rats fed low fat, choline deficient 
diets and given DMBA on day 50, had higher levels of inhibitory activity 
associated with their NK cell fraction, compared to the "cyclic" activ­
ity of their 65% and unseparated spleen cell populations, (b) rats fed 
high fat, choline deficient diets, and given DMBA on day 50, had levels 
of inhibitory activity associated with their NK cell fractions that 
slowly increased over a period of three weeks, compared to the low levels
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of inhibitory activity associated with their 65% and unseparated spleen 
cell populations, and (c) the inhibitory activity of the NK cell frac­
tion from rats on the low fat, choline deficient diet, and given DMBA 
on day 50, was much greater, early on, (days 56 through 70) compared to 
the inhibitory activity of the NK cell fraction from rats on the high 
fat, choline deficient diet, and given DMBA on day 50. These differ­
ences were due to the slow development of inhibitory activity of the NK 
cell fraction from the rats on the high fat, choline deficient diet, and 
given DMBA on day 50.
Ranking of Inhibitory Activity of NK Cells According to Diet
To further clarify the role of diet and carcinogen on. inhibitory 
activity of NK cells, data from each dietary group were analyzed, and 
the mean inhibitory activity expressed as the percent of control (YAC-1 
cell proliferation, alone) was calculated. The data were ranked from 
the highest to lowest value, along with each corresponding dietary group. 
Those groups whose inhibitory activity was not significantly different 
from other groups were designated with the same group letter. Those 
groups whose inhibitory activity was significantly different were 
designated by a different letter. Testing was performed using the Dun­
can's Multiple Range Test, with an alpha value of 0.05. The data in 
Table 2 revealed that on the average, NK cells from rats fed low fat 
diets, had the greatest ability to inhibit YAC-1 tumor cell prolifera­
tion, while NK cells from rats fed high fat, choline deficient diets, and 
given DMBA on day 50, had the least ability to inhibit YAC-1 tumor cell 
proliferation. When the NK cell inhibitory activity of rats from these 
two dietary groups was compared as a function of age (Figure 13), the
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data revaled that differences.were evident at all time points tested, 
(days 55-57, p = .0158; days 69-71, p = .0001; days 76-78, p = .0158; 
days 83-85, p = .0001; and days 90-92, p = .2700). In addition, the 
data in Table 2 also indicated that, on the average, rats fed low fat 
diets had NK cells whose inhibitory activity was greater, compared to 
rats fed high fat diets. DMBA caused little additional suppression of 
NK cell activity of rats on either diet. These averaged results indi­
cated that the mean values of NK cell activity of rats on the different 
diets could be used to rank dietary states which were correlated with 
different levels of NK cell activity, and that these mean values re­
flected the differences in NK cell activity when the data was previously 
compared with respect to age of the animal.
The Role of Low or High Fat Diets on NK Cell Number and Function 
To determine the role that diet played in inhibitory activity of 
NK cells, inhibitory activity of the NK cell fraction of all low fat 
diet groups, regardless of treatment, was plotted as seen in Figure 14. 
The resulting graph illustrated that most low fat dietary groups ex­
hibited a high level of inhibitory activity by their NK cell fractions 
from day 55 to day 84. The contrasting data (Figure 15) indicated that 
the inhibitory activity of rats fed the high fat diets appeared to be 
"cyclic" in nature, as previously noted, and, in addition, three out of 
four high fat dietary groups appeared to be synchronous in their "cyclic" 
responses. The data so far presented have indicated that high fat diets 
alone, and in combination with other factors such as DMBA and choline 
deficiency, resulted in animals whose inhibitory activity was "cyclic" 
and, on the average, lower than that of animals fed only low fat diets.
43
To further analyze the differences between the inhibitory activity
of rats fed low or high fat diets, other criteria of the spleen cell
populations used in these studies were examined for each combined low 
fat or high fat dietary group. As seen in Table 3, rats fed high fat 
diets had significantly greater numbers of spleen cells (p = .0144) and 
fewer percentages of NK cells (Fraction 2) compared to their low fat 
diet counterparts (p = .0177). In addition, rats fed high fat diets 
had more cells in the pellet (Fraction 4) compared to rats fed low fat 
diets (p = .0116). The smaller percentage of NK cells in spleens of 
rats fed high fat diets, however, was compensated by a larger total 
spleen cell number, and thus, when the total number of NK cells was cal­
culated for each dietary group, the results, expressed on a per spleen 
basis, were equal. Thus, NK cell number could not account for the 
differences in inhibitory activity as seen in rats fed low fat diets, 
compared to rats fed high fat diets.
To further investigate the differences in inhibitory activity 
between rats fed low fat and high fat diets, a comparison of NK cell 
proliferation was made. In the natural killer cell assay, NK cells were 
cultured alone, without YAC-1 targets, to assay for any spontaneous pro­
liferative response of the NK cells themselves. The data from all low 
fat dietary groups were combined, as well as all data from the high fat 
dietary groups. For each dietary group, the mean proliferative response 
of the NK cells cultured alone, for each animal, was ranked from the
lowest to highest value, and the values divided into quartiles. The
resulting data were analyzed for any correlations (see Table 4). Results 
revealed that an inverse correlation existed between the NK cell
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proliferative activity, and the ability of NK cells to inhibit YAC-1 
tumor cell proliferation. If proliferative activity of the NK cell 
fraction was low, the ability to inhibit YAC-1 proliferation was high.
As the proliferative activity of the NK cell fraction increased, its 
corresponding ability to inhibit YAC-1 proliferation decreased. This 
inverse correlation was true for both dietary groups. In addition, 
some animals on the high fat diets had NK cells whose mean proliferative 
activity was twice that of low fat animals, and whose ability to inhibit 
YAC-1 proliferation was decreased approximately two-fold. These results 
indicated that some of the animals fed high fat diets had lower levels 
of inhibitory activity, which might be due to a higher proliferative 
activity of their NK cells, compared to animals fed the low fat diet.
3Inhibition of Incorporation of H-thymidine by YAC-1 Tumor Cells 
Cultured With Spleen Cells from Rats Fed Low Fat or High Fat Diets
To verify the effects of low fat or high fat diet on the ability
3of spleen cells to inhibit the H-thymidine incorporation into YAC-1 
targets, a second experiment was designed, using rats placed on either 
a low fat or high fat diet, and assaying for inhibitory activity, start­
ing one week earlier (day 41) than the previous experiment. Data from 
the previous experiment were combined with the present experiment when 
the assay times fell on the same days.
Figure 16 compares the inhibitory activity of only the NK cell 
fractions from rats on a low fat diet, compared to rats fed a high fat 
diet. Rats fed a low fat diet had high levels of inhibitory activity 
early on, through day 48, never exceeding 10% incorporation. Starting 
on day 50, however, inhibitory activity decreased to a minimum value of
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55% incorporation by day 57. The inhibitory activity then increased, 
beginning on day 62 (40% incorporation), and continued on days 69, 76, 
and 83 (20%, 5%, and 1% incorporation, respectively). The inhibitory 
activity of the NK cell fraction from high fat diet fed rats ranged 
from 2% to 35% incorporation, between days 41 and 50. On day 55, how­
ever, no inhibitory activity could be demonstrated. This lack of inhib­
itory activity in high fat diet fed rats was significantly lower than 
the inhibitory activity expressed by the low fat diet fed rats at the 
same time point (p = .0500). The inhibitory activity increased on days 
57, 62, and 64, as shown by 58%, 50%, and 10% incorporation, respectively. 
This activity, however, decreased once again to 42% and 45% on days 76 
and 78. This low level of inhibitory activity of rats fed high fat diets 
was significantly lower, compared to the inhibitory activity of rats fed 
low fat diets as measured on day 76 (p = .0541). On day 85, the inhib­
itory activity of the NK cell fraction from rats fed high fat diets 
increased to 21% incorporation. The results from Figure 16 substantiated 
the previous data indicating that; (1) rats fed low fat diets had NK 
cells whose inhibitory was, on the average, higher than the inhibitory 
activity of the NK cells from rats on high fat diets, (b) this inhibitory 
activity of NK cells from rats on low fat diets was high, early on, and 
never exceeded 55% incorporation, and (c) rats fed high fat diets had NK 
cells whose inhibitory activity appeared to be "cyclic" in nature, com­
pared to the non-cyclic nature of NK cells from rats fed low fat diets.
3Inhibition of Incorporation of H-thymidine by RgTg Tumor Cells Cultured 
with Spleen Cells from Rats Fed Low Fat or High Fat Diets
To determine the effects of diet on the inhibitory activity of rat 
Spleen cells against a different target dell, rats were placed on either
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low fat or high fat diets, and inhibitory activity of the three spleen 
cell populations was measured, using the rat mammary adenocarcinoma 
cell line, RgTg, as the source of target cells.
The data from Figure 17 demonstrated that although the NK cell 
fraction exhibited the highest level of inhibitory activity at some time 
points (days 41 and 62), there were no significant differences in the 
inhibitory activity of the three spleen cell populations at the majority 
of the time points tested.
Figure 18 compares the inhibitory activity of the three spleen 
cell populations from rats fed high fat diet. The NK cell fraction was
3somewhat better able to inhibit the H-thymidine incorporation into RgTg 
tumor cells, compared to the 65% fraction or the unseparated spleen cell 
populations. The highest level of inhibitory activity of the NK cell 
fraction occurred on day 57 (50% incorporation). Thereafter, this inhib­
itory activity gradually decreased to 100% incorporation by day 76. The 
inhibitory activity of the 65% and the unseparated spleen cell popula­
tions was, on the average, lower, compared to the inhibitory activity of 
the NK cell fraction. A similar decrease in inhibitory activity was 
also observed for both spleen cell populations on day 76.
Figure 19 compares the inhibitory activity of only the NK cell 
fractions from rats on low fat diets and rats on high fat diets. There 
were essentially no significant differences between the inhibitory 
activity of NK cell fractions from the low fat or high fat diet fed rats. 
The results from Figures 17, 18, and 19 indicated that diet did not in­
fluence the inhibitory activity of any of the spleen cell populations 
tested, when using the RgTg tumor cell line as a source of target cells.
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Resistance of RgTg Tumor Cells to the Inhibitory 
Activity of Spleen Cell Fractions
To determine if RgTg tumor cells were resistant to the inhibitory 
activity of spleen cell fractions, the RgTg tumor cells were subjected 
to either one or two, 16 hour incubation periods with the 65% or NK 
fractions of spleen cells. Spleen cells were then removed, and the tumor 
cells allowed to continue growing for a total of 90 hours.
Figure 20 indicated that a 16 hour incubation of 5-2̂ 2 tumor cells 
with the 65% or NK fraction of spleen cells, plus a 24 hour incubation 
period without spleen cells, reduced the number of viable RgTg tumor 
cells from 3 x 10̂  to 2 x 10̂  for the 65% fraction, and from 3 x 10̂  to
41 X 10 for the NK cell fraction, by 40 hours. Further incubation with­
out spleen cells resulted in a renewed growth rate for all RgTg cells, 
regardless of exposure history. However, if RgTg tumor cells were incu­
bated with the 65% or NK cell fractions of spleen cells for an additional 
16 hours, the resulting growth of the RgTg tumor cells was inhibited.
The Figure demonstrated that R^Tg tumor cells, with a 65% or NK cell 
fraction history, were further inhibited by the additional 16 hour incu­
bation with either the NK or the 65% fractions of spleen cells. Further­
more, removal of spleen cell fractions after 40 hours of growth, resulted 
in a decline in subsequent growth of the tumor cells over an additional 
48 hour incubation period. These data indicated that; (a) NK cell- 
mediated inhibition of growth of RgTg tumor cells could be partially 
lifted if NK cells were removed after 16 hours, and tumor cells re­
incubated and (b) NK cell-mediated inhibition of RgTg tumor cell growth 
did not result in the emergence of resistant RgTg tumor cells, since
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re-incubation with additional NK cells and their subsequent removal, 
resulted in the establishment of RgTg tumor cell cultures which were 
unable to continue their growth.
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Table 1. Composition of diet for rats fed either low or 




POLYUNSATURATED 2% 2% LOW OR 20%LOW POLYUNSATURATEDFAT DIET FAT DIET FAT DIET CHOLINE DEFICIENT
GM GM GM
CASEIN 23 23 23
FAT 20̂ 2̂ 2 0 o r 2
SUCROSE 46 64 46 OR 64
ALPHACEL (NON NUTRIENT b u l k) 6 6 6
SALT MIXTURE^ 4 4 4
VITAMIN MDCTURe '̂ 1 1 '1
^CORN OIL; ^LINOLEIC ACID; ^HUBBELL SALT MIXTURE; ^ICN VITAMIN MIXTURE (below) (below)
SALT MIXTURE Percent VITAMIN MIXTURE grams per
100 lbs diet
Calcium Carbonate 54.300 Vitamin A Concentrate 4.5
Magnesium Carbonate 2.500 (200,000 units/gm)
Magnesium Sulfate 1.600 Vitamin D Concentrate 0.25
Sodium Chloride 6.900 (400,000 units/gm)
Potassium Phosphate (monobasic) 21.200 Ascorbic Acid 45.0
Ferric Phosphate 2.050 Inositol g 5.0
Potassium Iodide 0.008 Choline Chloride 75.0
Manganese Sulfate (HgO) 0.035 Menadione 2.25
Sodium Fluoride 0.010 p-Aminobenzoic Acid 5.0
Aluminum Potassium Phosphate 0.017 Niacin 4.5
Copper Sulfate 0.090 Riboflavin 1.0
Zinc Chloride (SH.O) 0.030 Pyridoxine Hydrochloride 1.0
Thiamine Hydrochloride 1.0
5 Calcium Pantothenate 3.0
(Choline Chloride is ommitted from the mgms./lOO lbs diet
vitamin mixture in diets that are de- Biotin 20.00
ficient in choline). Folic Acid 90.00
Vitamin B-12 1.35
Plate la. A representative field of unseparated spleen cells showing a large, granular 
lymphocyte, polymorphonuclear leukocyte, macrophages, and small to medium 
sized lymphocytes. Giemsa stain, lOOOX.
Plate lb. Appearance of cells obtained from the 55% atid 60% fractions of Percoll
density gradients. Numerous lymphocytes bearing a kidney-shaped nucleus, 
and azurophillic granules in the cytoplasm can be seen (large granular 
lymphocytes). Giemsa stain, lOOOX.
Plate Ic. Appearance of cells obtained from the 65% fraction of Percoll density 
gradients. Morphology is that of medium sized lymphocytes. .Giemsa 
stain, IQOOX.
Plate Id. YAC-1 tumor cells surrounded by three natural killer cells. YAC-1 tumor cell 
appears to be non-viable due to uptake of Trypan blue. YAC-1 tumor cell at 





3Figure 1. Inhibition of incorporation of ^H-thymidine into YAC-1 tumor cells cultured with 
the three spleen cell populations obtained from rats fed a low fat diet, as a function of age.
Tumor cells, spleen cells, and tumor-spleen cell cultures were grown for 16 hours, followed by the
3addition of 1.0 uCi of H-thymidine, and cultured for an additional 3.5 hours. Cells were harvested,
Oand the amount of H-thymidine incorporation determined. Inhibitory activity of each tumor-spleen 
cell culture was determined by measuring the amount of ^H-thymidine incorporation of the YAC-1-spleen 
cell culture, and expressing this as a percentage of the incorporation of the YAC-1 tumor cells 
cultured alone (control). The results were calculated using the following formula;
3% of Control H-thymidine Incorporation =
(cpm of Spleen cells 4- YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
designates spleen cells obtained from the NK fraction of Percoll from rats on low fat
diets, g. ■. ■ . .g| designates spleen cells obtained from the 65% fraction of Percoll from rats on
low fat diets. M ----- A  designates spleen cells not separated by Percoll obtained from rats on
low fat diets. Each point represents the mean of six determinations from two rats. Standard 
error of the mean is shown when it exceeds the symbol's dimensions.
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Figure 2. Inhibition of incorporation of thymidine into YAC-1 tumor cells cultured with 
the three spleen cell populations obtained from rats fed a high :fat 'diet, as a function of age.
Tumor cells, spleen cells, and tumor-spleen cell cultures were grown for 16 hours, followed by the
3addition of 1.0 uCi of H-thymidine, and cultured for an additional 3.5 hours. Cells were harvested,
3and the amount of H-thymidine incorporation determined. Inhibitory activity of each tumor-spleen
3cell culture was determined by measuring the amount of H-thymidine incorporation of the YAC-l-spleen 
cell culture, and expressing this as a percentage of the incorporation of the YAC-1 tumor cells 
cultured alone (control). The results were calculated using the following formula:
Ln3 Ln% of Control H-thymidine Incorporation =
(cpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) x 100
(cpm of YAC-1 cells cultured alone)
O o designates spleen cells obtained from the NK fraction of Percoll from rats on high fat
diets. □_____ □ designates spleen cells obtained from the 65% fraction of Percoll from rats on
high fat diets. A A designates spleen cells not separated by Percoll obtained from rats on
high fat diets. Each point represents the mean of six determinations from two rats. Standard
error of the mean is shown when it exceeds the symbol’s dimensions.
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3Figure 3. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured 
with NK cell populations obtained from rats fed a low fat diet compared to rats fed a high fat 
diet, as a function of age. Tumor cells, spleen cells, and tumor-NK spleen cell cultures were
3grown for 16 hours, followed by the addition of 1.0 uCi of H-thymidine, and cultured for an
3additional 3.5 hours. Cells were harvested, and the amount of H-thymidine incorporation 
determined. Inhibitory activity of each tumor-NK spleen cell culture was determined by measuring
3the amount of H-thymidine incorporation of the YAC-l-NK spleen cell culture and expressing this 
as a percentage of the incorporation of the YAC-1 tumor cells cultured alone (control). The 
results were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of NK spleen cells + YAC-1 cells) minus (cpm of NK spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
— 0 designates NK spleen cells obtained from rats on low fat diets. O------ Odesignates
NK spleen cells obtained from rats on high fat diets. Each point represents the mean of six
determinations from two rats. Standard error of the mean is shown when it exceeds the symbol's
dimensions.
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3Figure 4, Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
the three spleen cell populations obtained from rats fed a low fat diet and given DMBA at 50 days 
of age, as a function of age. Tumor cells, spleen cells, and tumor-spleen ceJ.l cultures were grown
3for 16 hours, followed by the addition of 1.0 uCi of H-thymidine, and cultured for an additional
33.5 hours. Cells were harvested, and the amount of H-thymidine incorporation determined. Inhib-
3itory activity of each tumor-spleen cell culture was determined by measuring the amount of H- 
thymidine incorporation of the YAC-l-spleen cell culture, and expressing this as a percentage of the
incorporation of the YAC-1 tumor cells cultured alone (control). The results were calculated using
the following formula:
3% of Control H-thymidine Incorporation =
(cpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
•...... @designates spleen cells obtained from the NK fraction of Percoll from rats on low fat
diets and given DMBA. ■ ...... B designates spleen cells obtained from the 65% fraction of Percoll
from rats on low fat diets and given DMBA. ........A  designates spleen cells not separated by
Percoll from rats on low fat diets and given DMBA. Each point represents the mean of six deter­
minations from two rats. Standard error of the mean is shown when it exceeds the symbol's 
dimensions.
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3Figure 5. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
the three spleen cell populations obtained from rats fed a high fat diet and given DMBA.at 50 
days of age, as a function of age. Tumor cells, spleen cells, and tumor-spleen cell cultures were
3grown for 15 hours, followed by the addition of 1.0 uCi of H-thymidine, and cultured for an
3additional 3.5 hours. Cells were harvested, and the amount of H-thymidine incorporation deter­
mined. Inhibitory activity of each tumor-spleen cell culture was determined by measuring the amount 
3of H-thymidine incorporation of the YAC-l-spleen cell culture, and expressing this as a percentage 
of the incorporation of the YAC-1 tumor cells cultured alone (control). The results were calculated 
using the following formula;
3% of Control H-thymidine Incorporation =
(cpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
G...... odesignates spleen cells obtained from the NK fraction of Percoll from rats on high fat
diets and given DMBA. o...... □ designates spleen cells obtained from the 65% fraction of Percoll
from rats on high fat diets and given DMBA. A ..... -A designates spleen cells not separated by
Percoll from rats on high fat diets and given DMBA. Each point represents the mean of six-deter­
minations from two rats. Standard error of the mean is shown when it exceeds the symbol's dimensions.
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3Figure 6. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured 
with NK cell populations obtained from rats fed a low fat diet and given DMBA at 50 days of age 
compared to rats fed a high fat diet and given DMBA, as a function of age. Tumor cells, spleen 
cells, and tumor-NK spleen cell cultures were grown for 16 hours, followed by the addition of
31.0 uCi of H-thymidine, and cultured for an additional 3.5 hours. Cells were harvested, and the
3amount of H-thymidine incorporation determined. Inhibitory activity of each tumor-NK spleen cell
3culture was determined by measuring the amount of H-thymidine incorporation of the YAC-l-NK spleen 
cell culture and expressing this as a percentage of the incorporation of the YAC-1 tumor cells 
cultured alone (control). The results were calculated using the following formula;
3% of Control H-thymidine Incorporation =
(cpm of NK spleen cells + YAC-1 cells) minus (cpm of NK spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
@...... ©designates NK spleen cells obtained from rats on low fat diets and given DMBA. O*»**
designates NK spleen cells obtained from rats on high fat diets and given DMBA. Each point 
represents the mean of six determination from two rats. Standard error of the mean is shown 
when it exceeds the symbol's dimensions.










3Figure 7. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
the three spleen cell populations obtained from rats fed a low fat, choline deficient diet, as a 
function of age. Tumor cells, spleen cells, and tumor-spleen cell cultures were grown for 16
3hours, followed by the addition of 1.0 uCi of H-thymidine, and cultured for an additional 3.5
Ohours. Cells were harvested, and the amount of H-thymidine incorporation determined. Inhibitory
3activity of each tumor-spleen cell culture was determined by measuring the amount of H-thymidine 
incorporation of the YAC-1-spleen cell culture, and expressing this as a percentage of the incor­
poration of the YAC-1 tumor cells cultured alone (control). The results were calculated using the 
following formula:
3% of Control H-thymidine Incorporation =
(cpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
#- —  — ©designates spleen cells obtained from the NK fraction of Percoll from rats on low fat,
choline deficient diets. B~ —  —  B designates spleen cells obtained from the 65% fraction of
Percoll from rats on low fat, choline deficient diets. A —  —  — designates spleen cells not
separated by Percoll from rats on low fat,, choline deficient diets. Each point represents the




















































3Figure 8. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
the three spleen cell populations obtained from rats fed a high fat, choline deficient diet, as a 
function of age. Tumor cells, spleen cells, and tumor-spleen cell cultures were grown for 16 hours,
3followed by the addition of 1.0 uCi of H-thymidine, and cultured for an additional 3.5 hours. Cells
3were harvested, and the amount of H-thymidine incorporation determined. Inhibitory activity of each
3tumor-spleen cell culture was determined by measuring the amount of H-thymidine incorporation of the 
YAC-l-spleen cell culture, and expressing this as a percentage of the incorporation of the YAC-1
tumor cells cultured alone (control). The results were calculated using the following formula;
3 3% of Control H-thymidine Incorporation =
(cpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
O—  —  — O designates spleen cells obtained from the NK fraction of Percoll from rats on high fat,
choline deficient diets. D—  —  — Odesignates spleen cells obtained from the 65% fraction of Percoll
from rats on high fat, choline deficient diets. A — —  — A  designates spleen cells not separated
by Percoll from rats on high fat, choline deficient diets. Each point represents the mean of six
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3Figure 9. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
NK cell populations obtained from rats fed a low fat, choline deficient diet compared to rats fed 
a high fat, choline deficient diet, as a function of age. Tumor cells, spleen cells, and tumor-
3NK spleen cell cultures were grown for 16 hours, followed by the addition of 1.0 uCi of H-thymidine,
3and cultured for an additional 3.5 hours. Cells were harvested, and the amount of H-thymidine 
incorporation determined. Inhibitory activity of each tumor-NK spleen cell culture was determined
3by measuring the amount of H-thymidine incorporation of the YAC-l-NK spleen cell culture and ex­
pressing this as a percentage of the incorporation of the YAC-1 tumor cells cultured alone (control).. 
The results were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of NK spleen cells + YAC-1 cells) minus (cpm of NK spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
—  — •designates NK spleen cells obtained from rats on low fat, choline deficient diets.
O—  —  — Odesignates NK spleen cells obtained from rats on high fat, choline deficient diets.
Each point represents the mean of six determinations from two rats. Standard error of the mean
is shown when it exceeds the symbol's dimensions.
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3Figure 10. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
the three spleen cell populations obtained from rats fed a low fat, choline deficient diet, and 
given DMBA on day 50, as a function of age. Tumor cells, spleen cells, and tumor-spleen cell cultures
3were grown for 16 hours, followed by the addition of 1.0 uCi of H-thymidine, and cultured for an
3additional 3.5 hours. Cells were harvested, and the amount of H-thymidine incorporation determined.
3Inhibitory activity of each tumor-spleen cell Ttulture was determined by measuring the amount of H- 
thymidine incorporation of the YAC-l-spleen cell culture, and expressing this as a percentage of the 
incorporation of the YAC-1 tumor cells cultured alone (control). The results were calculated using 
the following formula:
3% of Control H-thymidine Incorporation =
(cpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
O-------•designates spleen cells obtained from the NK fraction of Percoll from rats on low fat,
choline deficient diets and given DMBA. '— • —  Bdesignates spleen cells obtained from the 65%
fraction of Percoll from rats on low fat, choline deficient diets and given DMBA. A— ■ —  •— A
designates spleen cells not separated by Percoll from rats on low fat, choline deficient diets.and
given DMBA. Each point represents the mean of six determinations from two rats. Standard error of




























3Figure 11. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
the three spleen cell populations obtained from rats fed a high fat, choline deficient diet, and 
given DMBA on day 50, as a function of age. Tumor cells, spleen cells, and tumor-spleen cell
3cultures were grown for 16 hours, followed by the addition of 1.0 uCi of H-thymidine, and cultured
3for an additional 3.5 hours. Cells were harvested, and the amount of H-thymidine incorporation 
determined. Inhibitory activity of each tumor-spleen cell culture was determined by measuring the
3amount of H-thymidine incorporation of the YAC-l-spleen cell culture, and expressing this as a 
percentage of the incorporation of the YAC-1 tumor cells cultured alone (control). The results 
were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YÀC-1 cells cultured alone)
O------ O designates spleen cells obtained from the NK fraction of Percoll from rats on high fat,
choline deficient diets, and given DMBA. □-------□ designates spleen cells obtained from the 65%
fraction of Percoll from rats on high fat, choline deficient diets, and given DMBA. A   — A
designates spleen cells not separated by Percoll from rats on high fat, choline deficient diets,
and given DMBA. Each point represents the mean of six determinations from two rats. Standard
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3Figure 12. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
NK cell populations obtained from rats fed a low fat, choline deficient diet, and given DMBA on day 
50, compared to rats fed a high fat, choline deficient diet, and given DMBA on day 50, as a function 
of age. Tumor cells, spleen cells, and tumor-NK spleen cell cultures were grown for 16 hours,
3followed by the addition of 1.0 uCi of H-thymidine, and cultured for an additional 3.5 hours. Cells
3were harvested, and the amount of H-thymidine incorporation determined. Inhibitory activity of each
3tumor-NK spleen cell culture was determined by measuring the amount of H-thymidine incorporation of 
the YAC-l-NK spleen cell culture and expressing this as a percentage of the incorporation of the 
YAC-1 tumor cells cultured alone (control). The results were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of NK spleen cells + YAC-1 cells) minus (cpm of NK spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
• •—•designates NK spleen cells obtained from rats on low fat, choline deficient diets, and
given DMBA. G— • —  •— O designates NK spleen cells obtained from rats on high fat, choline deficient
diets, and given DMBA. Each point represents the mean of six determinations from two rats. Standard
error of the mean is shown whan it exceeds the symbol's dimensions.
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Table 2. Ranking of NK cell activity using Duncan's Multiple
Range Test. Tumor cells, NK spleen cells, and tumor-NK spleen cell
cultures were grown for 16 hours, followed by the addition of 1.0 
3uCi of H-thymidine, and were cultured for an additional 3.5 hours.
3Cells were harvested, and the amount of H-thymidine incorporation 
determined. Inhibitory activity was determined by measuring the
3amount of H-thymidine incorporation of the YAC-l-NK spleen cell 
culture and expressing it as a percentage of the incorporation of 
the YAC-1 tumor cells cultured alone. The results were calculated 
using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of NK spleen cells . (cpm of NK spleen cells ^
+ YAC-1 cells) cultured alone)
(cpm of YAC-1 cells cultured alone)
The mean of the percent of control incorporation (proliferation)
for all rats assayed in each dietary group was calculated and listed
in increasing order along with its corresponding dietary group
designation. The Duncan's Multiple Range Test was used to determine
differences between the means of each group. Groups with the same
letter were not significantly different at an alpha value of 0.05.
Groups with^the same letter were significantly different at an
alpha value of 0.05.
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Table 2.
RANKING OF NK CELL ACTIVITY USING 
DUNCAN'S MULTIPLE RANGE TEST
RANK DIET PERCENT OF CONTROL PROLIFERATION N GROUP
1 LOW FAT 11.7 42 A
2 HIGH FAT MINUS CHOLINE
17.2 42 B
3 LOW FAT PLUS DMBA 17.9 36 B
4 LOW FAT MINUS CHOLINE PLUS DMBA 20.1 36 B
5 HIGH FAT 26.8 39 C
6 LOW FAT MINUS CHOLINE 28.9 39 C
7 HIGH FAT PLUS DMBA 29.1 33 C
8 HIGH FAT MINUS CHOLINE PLUS DMBA 44.2 36 D
(g r o u p s  w i t h  t h e  SAME LETTER ARE NOT SIGNIFICANTLY DIFFERENT, GROUPS WITH DIFFERENT LETTERS ARE SIGNIFICANTLY DIFFERENT,a= 0,05)
3Figure 13. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
NK cell populations obtained from rats fed a low fat diet compared to rats fed a high fat, choline 
deficient diet, and given DMBA on day 50, as a function of age. Tumor cells, NK spleen cells, and
otumor-NK spleen cell cultures were grown for 16 hours, followed by the addition of 1.0 uCi of H- 
thymidine,, and cultured for an additional 3.5 hours. Cells were harvested, and the amount of H- 
thymidine incorporation determined. Inhibitory activity of each tumor-NK-spleen culture was deters
3mindd by measuring the amount of H-thymidine incorporation of the YAC-l-spleen cell culture, and
expressing this as a percentage of the incorporation of the YAC-1 tumor cells cultured alone (control).
The results were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of Spleen cells + YAC-1 cells ) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
•.u
VO
-©designates NK spleen cells obtained from rats on low fat diets, o— * — •— O designates
NK spleen cells obtained from rats on high fat, choline deficient diets, and given DMBA. Each 
point represents the mean of six determinations from two rats. Standard error of the mean is 
shown when it exceeds the symbol's dimensions.













3Figure 14. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
NK spleen cells obtained from rats on low fat diets, with or without choline, and with or without 
being given DMBA on day 50. Tumor cells, NK spleen cells, and tumor-NK spleen cell cultures were
3grown for 16 hours, followed by the addition of 1.0 uCi of H-thymidine, and cultured for an add-
3itional 3.5 hours. Cells were harvested, and the amount of H-thymidine incorporation determined.
Inhibitory activity of each tumor-NK spleen cell culture was determined by measuring the amount 
3of H-thymidine incorporation of the YAC-l-NK spleen cell culture, and expressing this as a per­
centage of the incorporation of the YAC-1 tumor cells cultured alone (control). The results were 
calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of NK spleen cells + YAC-1 cells) minus (cpm of NK spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
designates NK spleen cells obtained from rats on low'fat diets. @ ®  designates
NK spleen cells obtained from rats on low fat, choline deficient diets. O ...... @ designates
NK spleen cells obtained from rats on low fat diets and given DMBA. 9------ @ designates NK
spleen cells obtained from rats on low fat, choline deficient diets, and given DMBA. Each point 
represents the mean of six determinations from two rats. Standard error of the mean is shown 
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3Figure 15. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
NK spleen cells obtained from rats on a high fat diet, with or without choline, and with or without 
being given DMBA on day 50, as a function of age. Tumor cells, NK spleen cells, and tumor-NK-spleen
3cell cultures were grown for 16 hours, followed by the addition of 1.0 uCi of H-thymidine, and
3cultured for an additional 3.5 hours. Cells were harvested, and the amount of H-thymidine in­
corporation determined. Inhibitory activity of each tumor-NK-spleen cell culture was determined
3by measuring the amount of H-thymidine incorporation of the YAC-l-NK spleen cell culture, and 
expressing this as a percentage of the incorporation of the YAC-1 tumor cells cultured alone 
(control). The results were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of NK spleen cells 4- YAC-1 cells) minus (cpm of NK spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
O Odesignates NK spleen cells obtained from rats on high fat diets, o—  —  — G designates
NK spleen cells obtained from rats on high fat, choline deficient diets. O ...... ©désignâtes
NK spleen cells obtained from rats on high fat diets and given DMBA. 0 ~ -----©designates NK
spleen cells obtained from rats on high fat, choline deficient diets, and given DMBA. Each point 
represents the mean of six determinations from two rats. Standard error of the mean is shown when 
it exceeds the symbol's dimensions.
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Table 3. Characteristics of spleen cells taken from rats 
maintained on low fat or high fat diets. Diet groups were designated 
as either low fat or high fat, regardless of carcinogen treatment 
or choline deficiency. Mean values for each of the spleen cell 
characteristics were determined for each diet group. The Student's 
t-tgst was ueed to determine differences between the means.
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Table 3.
CHARACTERISTICS OF SPLEEN CELLS TAKEN FROM RATS
MAINTAINED ON LOW FAT OR HIGH FAT 
48 - 93 DAYS OLD
DIETS
MEAN VALUES, L OW £AI HIGH, EAT
SPLEEN WEIGHTS (g RAMS) 470.95 ± 11.85 475,56 ± 13.51
SPLEEN CELL NUMBER X i f 15.06 + 0.67 17.69 ± 0.82*
PERCENT NON-ADHERENT TO PLASTIC BEADS 57.13
+ 1.49 57.43 ± 1.84
PERCENT RECOVERED FROM PERCOLL GRADIENT 70.13
+ 1.66 76.16 ± 1.91
DISTRIBUTION OF CELLS ON PERCOLL GRADIENT(p e r c e n t )
7.74 + 0.52 6.55 ± 0.41
m w
23.11 + 1.01 19.49 + 1.11*
3 27.83 + 1.19 23.31 + 1.21
FRACTION 4 (pellet) 38.73
+ 2.13 46.29 ± 1.98*
NUMBER OF CELLS PER SPLEEN OF FRACTION 2 1.98 1.98
(x 10̂ ) 
p 1 0,018
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Table 4. Correlation between NK cell proliferation and 
ability to inhibit YAC-1 proliferation. Tumor cells, NK spleen 
cells, and tumor-NK spleen cell cultures were grown for 16 hours,
3followed by the addition of 1.0 uCi of H-thymidine, and were 
cultured for an additional 3.5 hours. Cells were harvested,
3and the amount of H-thymidine incorporation determined. Inhibitory
3activity was determined by measuring the amount of H-thymidine 
incorporation of the YAC-l-NK spleen cell culture and expressing 
this as a percentage of the incorporation of the YAC-1 cells 
cultured alone (control). The results were calculated using the 
following formula:
3% of Control H-thymidine Incorporation =
(cpm of NK spleen cells . (cpm of. NK spleen cells
+ YAC-1 cells) cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
The cpm of NK cell proliferation was listed from the smallest to
the largest value along with each corresponding NK + YAC-1 cpm
value and percent of YAC-1 proliferation. All data was analyzed
from all dietary groups, an . was divided into either low fat or
high fat diet categories, regardless of carcinogen treatment or
choline deficiency. Each of the groups was further divided into
four subgroups and the means calculated for each subgroup.
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Table 4.
CORRELATION BETWEEN NK CELL PROLIFERATION AND 
ABILITY TO INHIBIT YAC-1 PROLIFERATION
LOW FAT
NK CELLS ALONE NK + YAC-1 PERCENT OF YAC-1 N
(c p m) (c p m) PROLIFERATION -
1699 + 230 44042 + 17699 12.6 + 5.4 12
2825 ± 142 66222 + 25885 16.9 + 6.3 14
3831 ± 137 84867 + 36842 23.8 + 8.2 14
6044 + 582 85145 + 37233 23.0 + 11.0 12
HIGH FAT
846 ± 149 18196 + 2665 5.2 + 0.9 12
2457 + 171 100403 + 25515 22.8 + 5.6 14
5415 + 533 126211 + 23381 33 . 6 :■ 5 . 8 14
13167 + 2481 189821 + 44613 52.7 +12.5 12
3Figure 16. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
NK cell populations obtained from rats on low fat or high fat diets, as a function of age. Tumor cells,
NK spleen cells, and tumor-NK spleen cell cultures were grown for 16 hours, followed by the addition
3of 1.0 uCi of H-thymidine, and cultured for an additional 3.5 hours. Cells were harvested, and
3the amount of H-thymidine incorporation determined. Inhibitory activity of each tumor-NK spleen cell
3culture was determined by measuring the amount of H-thymidine incorporation of the YAC-l-NK spleen 
cell culture, and expressing this as a percentage of the incorporation of the YAC-1 tumor cells
cultured alone (control). The results were calculated using the following formula:
3 S% of Control H-thymidine Incorporation =
(cpm of NK spleen cells + YAC-1 cells) minus (cpm of NK spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
•------ •designates NK spleen ce? Is obtained from rats on low fat diets. O------O designates NK
spleen cells obtained from rats on high fat diets. Each point designated by an asterisk represents 
the mean of twelve determinations from four rats. All others represent the mean of six determinations 









41 43 55 5748 50 62 64 69 71 76 78 83 85
VOO
AGE OF RATS (d AYS) 
Figure 16.
3Figure 17. Inhibition of incorporation of H-thymidine into tumor cells cultured with
the three spleen cell populations obtained from rats fed a low fat diet, as a function of age.
Tumor cells, spleen cells, and tumor-spleen cell cultures were grown for 16 Hours, followed by
3removal of the spleen cells, and the addition of 1,0 uCi of H-thymidine to the tumor cell mono­
layers, These cells were incubated for an additional 3,b hours, removed with trypsin;EDTA, and
harvested. Inhibitory activity of each tumor-spleen cell culture was measured by determining the 
3amount of H-thymidine incorporation of the RgTg tumor cell-spleen cell culture and expressing this
as a percentage of the incorporation of the RT_ tumor cells cultured alone (control). The results
!
were calculated using the following formula:
I o
! % of Control H-thymidine Incorporation =
; (cpm of spleen ceils + R»T_ tumor cells)
X =100
(cpm of RgTg cells cultured alone)
-® designates spleen cells obtained from the NK fraction of Percoll from rats on
low fat diets, ■-------B designates spleen cells obtained from the 65% fraction of Percoll
from rats on low fat diets, ^ ..... A designates spleen cells not separated by Percoll obtained
from rats on low fat diets. Each point represents the mean of six determinations from two rats. 
Standard error of the mean is shown when it exceeds the symbol's dimensions.
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3Figure 18. Inhibition of incorporation of H-thymidine into RgTg tumor cells cultured with 
the three spleen cell populations obtained from rats fed a high fat diet, as a function of age. 
Tumor cells, spleen cells, and tumor-spleen cell cultures were grown for 16 hours, followed by
3the removal of the spleen cells and the addition of 1.0 uCi of H-thymidine to the tumor cell 
monolayers. These cells were incubated for an additional 3.b hours, removed with trypsin;EDTA, 
and harvested. Inhibitory activity of each tumor-spleen cell culture was measured by determining
3the amount of H-thymidine incorporation of the RgT^ tumor-spleen cell culture and expressing
this as a percentage of the incorporation of the ^2^2 cells cultured alone (control). The
results were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of spleen cells + R,T tumor cells)
X 100
(cpm of R2T2 cells cultured alone)
O------ Odesignates spleen cells obtained from the NK fraction of Percoll from rats on high fat
diets. □------13 designates spleen cells obtained from the 65% fraction of Percoll from rats on
high fat diets. - ̂ ------^designates spleen cells not separated by Percoll obtained from rats on
high fat diets. Each point represents the mean of six determinations from two rats. Standard 
error of the mean is shown when it exceeds the symbol's dimensions.
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3Figure 19. Inhibition of incorporation of H-thymidine into RgTg tumor cells cultured with 
NK spleen cell populations obtained from rats fed a low fat diet compared to rats fed a high fat 
diet, as a function of age. Tumor cells, NK spleen cells, and tumor-NK spleen cell cultures were 
grown for 16 hours, followed by the removal of the NK spleen cells and the addition of 1.0 uCi
3of H-thymidine to the tumor cell monolayers. These cells were incubated for an additional 
3.5 hours, removed with trypsin;EDTA, and harvested. Inhibitory activity of each tumor-NK
3spleen cell culture was measured by determining the amount of H-thymidine incorporation of 
the RgTg tumor-NK spleen cell culture and expressing this as a percentage of the incorporation 
of the RgTg tumor cells cultured alone (control). The results were calculated using the following 
formula:
3% of Control H-thymidine Incorporation =
(cpm of NK-spleen cells + R_T cells)
X 100
(cpm of RgTg cells.^cultured alone)
► designates NK spleen cells obtained from rats on low fat diets. Q  ■G  designates
NK spleen cells obtained from rats on high fat diets. Each point represents the mean of six 
determinations from two rats. Standard error of the mean is shown when it exceëds the symbol's 
dimensions.
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Figure 20. Number of viable RgTg tumor cells after exposure to spleen cell populations as 
a function of time. tumor cells were cultured with various spleen cell populations for
16 hours. Spleen cells were removed, and the cultures reincubated for 8 hours. NK cells were 
then added to some cultures, while media was added to others, and the cultures incubated for an 
additional 24 hours. NK cells were removed and replaced with fresh media. Numbers of viable 
RgTg tumor cells were determined at subsequent time points.
indicate RgTg tumor cells cultured with media only.
-■indicate RgTg tumor cells cultured for 16 hours with spleen cells obtained from the 65% 
fraction of Percoll from animals on low fat diets.
Jkindicate RgT^ tumor cells cultured for 16 hours with spleen cells obtained from the NK
fraction of Percoll from animals on low fat diets.
O—  —  — O indicate R^Tg tumor cells cultured with media for 16 hours plus NK cells for an additional 
16 hours.
)}— —  — O indicate RgTg tumor cells cultured with the 65% fraction of spleen cells for 16 hours plus 
NK cells for an additional 16 hours.
A —  —  ~AIndicate RgTg tumor cells cultured with NK cells for 16 hours plus an additional 16 hour 
incubation with NK cells.
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CHAPTER IV
DISCUSSION
The incidence of DMBA-induced mammary adenocarcinomas in female, 
Sprague-Dawley rats was dependent on the quantity and type of dietary 
fats (8,9,10,28). Rats fed low fat diets and given 10 mg of DMBA on 
day 50, began developing tumors 8 weeks following exposure to the 
carcinogen, reaching a maximum tumor incidence of 40% by 34 weeks 
following carcinogen. In addition, rats fed high fat diets had more 
tumors per tumor-bearing rat, compared to rats fed low fat diets.
The mechanism(s) by which high fat diets promote tumor growth are 
not known, however, results from some studies have suggested that high 
fat diets suppressed various vivo aspects of the immune response.
Feeding or injecting linoleic acid prolonged the skin allograft survival 
in rodents (46,67,92,120). More specifically, Hillyard and Abraham (44) 
reported that as little as 0.1% of cis-cis-linoleic acid added to a fat 
free diet, enhanced the transplantation of two mammary tumor cell lines 
into •. BALB/c mice. Other studies have indicated that polyunsaturated fats 
might be beneficial as an adjunct to immuno-suppressive theory, follow­
ing renal transplantation (60,64,66,69.
The influence of fats on the immune response as measured by in 
vitro studies have indicated that the proliferation of lymphocytes by 
mitogens or allogeneic cells could be inhibited by both saturated fats 
polyunsaturated fatty acids (65,68,77). Recent studies in our laboratory - 
have demonstrated that the concanavalin A-induced blastogenesis of spleen
99
100
lymphocytes was significantly inhibited when lymphocytes from rats on a 
high, polyunsaturated fat diet (20% corn oil) were compared to lympho­
cytes from rats on a low fat diet. This responsiveness was partially 
dependent on the source of serum used in the culture, since lymphocytes 
from rats fed a low fat diet were suppressed in serum from rats fed a 
high fat diet. Conversely, lymphocytes from rats fed a high fat diet 
responded better in serum obtained from rats fed a low fat diet compared 
to their autologous serum response. Although the response of high fat 
lymphocytes was improved when cultured in low fat serum, compared to auto­
logous serum, the response did not equal the response of low fat lympho­
cytes cultured in their autologous serum (57). This suggested that lym­
phocytes from high fat diet fed rats were probably inherently defective.
In another study (56), the combined effects of carcinogen (DMBA) and high 
fat diet were examined for their ability to inhibit lectin-induced blas­
togenesis. The results indicated that DMBA further suppressed lymphocyte 
responsiveness, regardless of type of diet fed.
There are several lines of evidence that suggest that natural 
killer cells might play a role in host defense against tumors. The prem­
ise of the immune surveillance theory is that tumor development should 
be associated with depressed immunity. Studies by Roder (94) e^ al. 
reported that patients with Chediak-Higashi syndrome had a marked deficit 
of NK cell activity and, in addition, had a high incidence of lymphomas. 
Roder and Duwe (93) also reported that a colony of beige mice, which had 
a genetically linked suppressed NK cell activity, also had a high inci­
dence of lymphomas. Studies by Gorelick and Herberman (32) showed that 
the carcinogen, urethane, caused lung tumors in susceptible strains of
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of mice which also had suppressed NK cell activity, while mice which were 
resistant to tumors caused by urethane, had normal levels of NK cell 
activity.
The effects of high fat diets on natural killer cell activity have 
not previously been reported. If high fat diets were shown to be sup­
pressive to one type of in vitro immune response, the effects of high fat 
diet on natural killer cell function might be predicted.
Our studies indicated that rats fed high fat diets, generally had 
lower levels of inhibitory activity associated with their NK cell frac­
tions, directed against YAC-1 tumor cell targets, compared to that of 
rats fed low fat diets. In addition, these lower levels appeared to be 
"cyclic" in nature, with a periodicity of approximately 3 weeks. The 
presence of "cyclic" immune phenomena has been reported by other inves­
tigators. An early study by Barrett and Hansen (2), reported that dif­
ferent groups of BALB/c mice which were challenged at various time points 
with allogeneic tumor cells, demonstrated varying degrees of tumor immun­
ity, measured by tumor incidence. When the data was analyzed with 
respect to time, they found that these fluctuations in immunity appeared 
to be cyclic in nature, with a periodicity of about 2 weeks. Simpson 
and Beverley (105) reported a similar observation of "cyclic" responses 
of lymphocyte cytotoxicity toward a tumor xenograft in CBA mice. They 
reported that spleen lymphocytes obtained from CBA mice which had been 
injected with hamster tumor cells (Tr), demonstrated cyclic cytotoxicity 
towards these tumor cells. Levels of cytotoxicity peaked on days 10, 18, 
and 40. The response of lymphocytes from lymph nodes, however, showed 
only one peak response on day 10, followed by a gradual decline in
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cytotoxicity through day 40. This differential, organ specific, activ­
ity of lymphocyte responsiveness in relation to its "cyclic" response 
pattern was postulated to be related to the formation of antigen-antibody 
complexes (105,121). The only other report of "cyclic" responses of 
natural killer cell activity, other than the present study, stem from 
work by Fernandes and Good (24), in which they describe a type of cycle 
associated with natural killer cell activity in male inbred, Fischer 
rats. This cycle was described as being circadian in nature, with maxi­
mum and minimal NK cell activities correlated with similar cyclic 
responses of rectal temperatures.
In the present study, the inhibitory activity of NK cells from 
rats on high fat diets appeared to cycle twice, while the inhibitory 
activity of NK cells from rats on a low fat diet cycled only once. These 
same types of cyclic responses were also observed in rats fed either lew 
fat of high fat diets, and given 10 mg of DMBA at 50 days of age. Our 
studies also indicated that DMBA administration had no suppressive effect 
on the "cyclic" inhibitory activity of NK cells obtained from these rats 
compared to non-DMBA treated rats. In contrast, studies reported by 
Erlich eit al. (20) indicated that 6 weekly intragastric feedings of 1 mg 
of DMBA to BALB/c mice resulted in suppression of their NK cell activity, 
measured against the YAC-1 lymphoma cell line. This suppression started 
2 weeks after the last DMBA feeding, and continued for 6 weeks. There 
was also a corresponding loss in spleen cell number from 40% to 80% of 
the total number of spleen cells found in untreated animals of that age. 
By 7 weeks following the carcinogen, both the NK cell activity and the 
number of spleen cells had started to increase, with a return of normal
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levels of NK cell activity and spleen cell numbers by 8 weeks of age.
The lack of suppression of NK cell activity in our system might be due 
to the fact that a single exposure to carcinogen might not be as sup­
pressive to NK cell activity compared to multiple exposures to carcinogen 
over an extended period of time. The interesting observation was that 
the major differences in inhibitory activity of high fat diet fed ani­
mals compared to low fat diet fed animals regardless of carcinogen, lay 
in the suppressed inhibitory activity of the high fat diet fed animals,
following day 50. The interval between days 30 and 63 has been shown to
be the critical time interval for carcinogen to be administered to 
Sprague-Dawley female rats, in order for maximum tumor induction to 
occur (49). Some investigataors have suggested that this time interval 
correlates with the rapid proliferation of cells in the rat mammary 
gland (96), and thus maximizes effects of DNA damage, brought about by 
an increase in DMBA binding affinity to DNA (49,96). The time interval 
of 64-76 days was the period in which our rats on high fat diets experi­
enced a second cyclic decrease in inhibitory activity associated with 
their spleen cell fractions, compared to rats on a low fat diet, whose
inhibitory activity was at a maximum. If NK cell activity vitro cor­
relates with an ̂  vivo immune surveillance mechanism (40), the "cyclic" 
variations in inhibitory activity of NK cell fractions from high fat 
diet fed animals, might reflect defective NK cell function, during a 
critical time period in which tumor foci might be developing. The lack 
of functional NK cells during this time period might eventually result 
in the successful establishment and continued growth of these tumor foci. 
This defective NK cell function might also be related to the proliferative
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capability of the NK cell itself. The data from table 4 demonstrates an 
inverse correlation between the amount of proliferation of NK cells cul­
tured alone, with their corresponding ability to inhibit YAC-1 tumor 
cell proliferation. This data clearly demonstrated that when NK cells 
had low levels of proliferation, their corresponding inhibitory activity 
towards YAC-1 targets was high, while NK cells, whose proliferation was 
high, had low levels of inhibitory activity towards YAC-1 targets. NK 
cells obtained from animals on high fat diets which had highest levels 
of proliferation had correspondingly lowest levels of inhibitory activity 
towards YAC-1 targets. This suggested that NK cells which were in the 
proliferative pool, could not participate in NK cell-mediated immune 
reactions. Since animals on high fat diets had NK cells whose prolifer­
ative capacity was high, the consequence of being fed a high fat diet 
might be the production of more total NK cells to compensate for the 
fewer active NK cells. When the data on percentages of NK cells recovered 
from either low fat diet fed, or high fat diet fed animals was analyzed, 
however, there were significantly more cells in the NK cell fraction of 
rats on the low fat diet, compared to rats on the high fat diet. However, 
rats on the high fat diet also had a larger spleen cell number compared 
to the rats fed the low fat diet. When the number of NK cells was ex­
pressed on a per spleen basis, however, the number of NK cells in the 
low fat or high fat diet fed groups was identical.
There were no apparent differences in the inhibitory activity of 
NK cells from rats fed only low fat choline deficient diets, compared to 
rats fed only high fat choline deficient diets. However the combination 
of high fat diet, choline deficiency, and DMBA resulted in rats whose
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inhibitory activity was severely suppressed and slow to develop, com­
pared to rats fed low fat, choline deficient diets and given DMBA. This 
was interesting due to the fact that previous studies by Lombardi e^ al. 
and Shinozuka e^ al. (62, 104) have demonstrated that rats fed corn oil 
diets, deficient in choline, had a greater incidence of hepatomas induced 
by ethionine or 2-acetylaminofluorine compared to rats fed choline sup­
plemented diets. In addition, a parallel study in this laboratory, mea­
suring the tumor incidence of animals placed on the various test diets, 
demonstrated that those animals which were fed high fat, choline deficient 
diets, and given DMBA on day 50, developed palpable mammary tumors, two 
weeks earlier than those animals on the high fat diet and similarly given 
DMBA on day 50, although the final tumor incidence, number of tumors per 
tumor bearing rat, and the tumor mass were identical in rats fed high fat 
or high fat, choline deficient diets at 20 weeks of age.
The combined conditions of high fat diet, choline deficiency and 
DMBA further suggested a synergistic relationship of suppressive effects 
on NK cell activity, since rats fed this diet regimen were the lowest in 
their ability to inhibit YAC-1 tumor cell proliferation compared to any 
other dietary condition tested.
The early appearance of tumors in the parallel study, and the sup­
pressed NK cell activity of rats fed high fat, choline deficient diets 
and given DMBA reported here, again suggested a possible relationship 
between early suppression of NK cell activity and the ability of tumor 
foci to develop. However, a direct cause and effect relationship between 
suppressed NK cell activity and development of tumors was not demon­
strated by this data.
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One of the reasons for using the YAC-1 murine lymphoma for rat NK 
cell assays was that the YAC-1 cell line is the standard tumor cell tar­
get used to assay for NK cell activity in rats and mice (5,6,13,18,24,
30) due to its relative sensitivity to NK cell lysis (38,39,40,41,42,43, 
52,63,78,79,§1). The series of experiments using the RgTg rat mammary 
adenocarcinoma cell line was an attempt to demonstrate a similar suppres­
sive fat effect, using a target cell that was more closely related to 
the actual tumor that these animals developed when exposed to the car­
cinogen. Data was collected and analyzed for inhibitory activities of 
spleen cell fractions against the RgTg tumor cell line, from rats fed 
either a low fat diet or a high fat diet. Data from DMBA and/or choline 
deficient diet fed rats was not included because early tumor foci that 
might be developing in DMBA treated animals might sensitize lymphocytes 
in the spleen. If this were the case, the assays would be measuring not 
only NK cell activity against the RgTg cell line, but also specific cyto­
toxicity of sensitized lymphocytes towards the R^Tg tumor cells. The 
data revealed that although there were differential inhibitory effects
3of the three spleen cell populations on the incorporation of H-thymidine 
into the RgTg tumor cell targets, there was no significant difference in 
the ability of NK cells from rats on a low fat diet, to inhibit the
3incorporation of H-thymidine by R^T^ targets compared to the inhibitory 
activity of NK cells from rats fed high fat diets. In addition, the 
inhibitory activity of NK cells towards RgTg targets was never lower
3than 55% of control H-thymidine incorporation compared to the greater 
inhibition of proliferation of the more sensitive YAC-1 target. There 
are several reasons that could explain low levels of inhibitory activity
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of NK cells against RgTg tumor targets. First, the RgTg cell line is a 
non-lymphoid cell line. Several investigators (43,52,101) have pointed 
out that lymphoid cell lines are more sensitive to NK cell activity than 
non-lymphoid cell lines. Secondly, the RgTg cell line grows as an adher­
ent monolayer. Stutman £t (110) have recently reported that YAC-1 
cells grown in artificial monolayers were resistant to natural killer 
cell attack, but were lysed when grown as suspension cultures. The ad­
herence of RgTg cells to plastic substrate might at least, in part, pro­
tect some parts of each cell from NK cell binding and subsequent inhib­
itory activity. The third reason for observing low levels of inhibitory 
activity against RgTg tumor cells may be inadequate incubation periods 
with NK cells. Studies using R2^2 targets used incubation times
which were sufficient to inhibit the growth of the sensitive YAC-1 tumor 
cell. A longer incubation time might be required to demonstrate higher 
levels of inhibitory activity of NK cells against RgTg tumor cells. 
Finally, the fourth reason for low NK cell activity against RgTg tumor 
cells might be in the nature of the tumor cell line itself. The Iri vitro 
culturing of the original cell line may have selected for certain popu­
lations of tumor cells that no longer reflect the characteristics of in 
vivo tumor cells, and thus are insensitive to NK cell attack. Our stud­
ies however, did indicate that if RgTg tumor cells were exposed to two 
16 hr periods of culture with NK cells, their subsequent growth, after 
removal of NK cells, was inhibited for an additional 50 hours. However, 
a growth curve with zero slope could be interpreted in two ways; (1) NK 
cells could be cytostatic against R^Tg tumor cells or (2) NK cells could 
be cytolytic with cell division cell and death of RgTg tumor cells being 
equal.
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3The correlation between inhibition of H-thymidine uptake and 
actual killing of tumor cells by NK cells is a more difficult question to 
answer. The standard assay used for demonstrating NK cell activity 
utilizes a 4 hour, ^^Cr release assay to detect lysis of ^^Cr labelled 
tumor cell targets by NK cell populations. In addition, high effector 
to target cell ratios are used (100:1) to ensure detection of target cell 
killing as measured by release of ^^Cr into the media by lysed target 
cells. This method however, is limited due to the fact that some tumor 
cell lines release ^^Cr spontaneously into the media if longer incubation 
times (8 to 12 hours) are employed (7). The inhibition assay employed 
in the present study may indeed reflect a combination of cytostasis and 
cytolysis in as far as the YAC-1 cell line is concerned. This is based 
on the observations that some YAC-1 tumor cells bound to NK cells fail 
to exclude trypan blue, indicating that cytolysis has taken place. How­
ever, some NK cells also were observed to be bound to YAC-1 cells which 
appeared to be viable. These results however were based on a limited 
amount of data obtained from YAC-1 NK cell cultures.
The separation of spleen cell populations using Percoll density 
gradient centrifugation appeared to be a convenient method to enrich 
spleen cell populations for natural killer cell activity. This method 
was very similar to the method recently described by Reynolds et al. (89). 
One main difference between the present study and their work is the 
natural killer cell activity in nylon wool passed rat spleen cells was 
enriched in the 44.2% and 47.5% fraction of Percoll, compared to the 
enrichment in inhibitory activity of our NK cells in the 55% and 60% 
Percoll fractions.
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The interesting observation in studies was that the 55% and 60% 
fractions of Percoll separated cells were enriched also with large 
granular lymphocytes (LGL), described by Reynolds at al. (89), as being 
present in their 44.2% and 47.5% Percoll fractions. Although LGL mor­
phology has yet to be designated as a unique marker for NK cells (89,115), 
the appearance of these cells in our 55% and 60% Percoll fractions indi­
cated that the inhibitory activity of these types of NK cells reported 
in this study, probably are the same cells which have been described as 
"killers" in ^^Cr release assays and further lend support to the idea
3that natural killer cell activity can be related to inhibition of H- 
thymidine uptake by tumor cell targets.
The present study indicated a relationship of diet to inhibitory 
activity of natural killer cells. The correlation of low inhibitory 
activity of NK cells with rats fed high fat, choline deficiency diets, 
and given DMBA could be further extended to animals fed high fat diets, 
regardless of carcinogen or choline deficiency. The presence of pro­
liferating NK cells in NK cell fractions of rats fed high fat diets could 
also be correlated with low inhibitory activity of these NK cell popula­
tions. These correlations in the decreased ability of NK cells from
3rats fed high fat diets, to inhibit H-thymidine incorporation into tumor 
cell targets, were only valid for reactions involving the YAC-1 tumor 
cell line. The inability to show diet related differences in NK cell 
inhibitory activity against the RgTg tumor cell line probably was related 
to a number of factors, including the nature of the target cell itself. 
The association of LGL morphology to NK cell fractions confirmed the 
earlier work of Reynolds et al. (89) in the rat, and Timonen eĵ  (115)
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in the human. The significance of NK cells in protection of animals 
from primary tumors, induced by carcinogenic agents is not known. How­
ever, recent work by Flannery et̂ al. (25) has shown suggestive evidence 
that NK cells may play an important vivo role in host response to 
chemically-induced, solid tumors. He reported that NK cells were present 
as infiltrates into two 3-methylcholanthrene induced sarcomas which had 
been transplanted into syngeneic Wistar rats. These NK cells had cyto­
lytic reactivity towards a number of vitro derived cell lines tested. 
There was no evidence of specific cytotoxicity against the tumor of 
origin.
Ifhether or not NK cells play an vivo role in the host response 
to DMBA-induced rat mammary tumors is currently under investigations.
Our present studies have attempted to correlate some of the factors, such 
as high fat diet, choline deficiency, and DMBA, which have been demon­
strated to be important in the establishment of rat mammary tumors, with 
suppressed vitro NK cell activity. Further studies are necessary to 
determine whether or not specific augmentation of suppressed NK cell 
activity in rats on high fat, choline deficient diets and given DMBA, 
would result in protection of these animals from subsequent tumor growth, 
and thus define an vivo role for natural killer cells in host defense 
against DMBA-induced mammary tumors.
CHAPTER V
SUMMARY
3The incorporation of H-thymidine into YAC-1 lymphoma cells was 
inhibited when Percoll separated, rat spleen cell fractions and unsepar­
ated spleen cells were cultured with YAC-1 tumor cells. The greatest 
inhibition occurred with spleen cells obtained from the 55% and 60% Per­
coll fractions. These cells were characterized as being large granular 
lymphocytes which were non-adherent to plastic, and hence, were desig­
nated as natural killer (NK) cells.
The inhibitory activity of NK cells was dependent on the quantity 
of fat in the diet of the rats from which these cells were obtained.
Rats which were fed a 20% corn oil diet (high fat) generally had lower 
levels of inhibitory activity against YAC-1 tumor cells compared to rats 
fed a diet containing 2% linoleic acid (low fat). While choline defi­
ciency or treatment with DMBA did not alter NK cell activity in either 
dietary group, the combination of both conditions caused a significant 
reduction in NK cell activity when rats were maintained on a high fat 
diet.
The proliferative activity of NK cells was generally higher in 
rats on the high fat diet compared to rats on the low fat diet. NK- 
induced inhibition of YAC-1 cell proliferation correlated inversely with 
the proliferative activity of the NK cells. Some of the rats fed high 
fat diets had NK cells whose proliferative activity was approximately
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twice that of rats fed low fat diets, and whose corresponding inhibitory 
activity against YAC-1 tumor cells was one-half that of rats on low fat 
diets.
NK cell activity was not constant during the peridd of study, but 
tended to display cyclic responses, particularly in rats on the high fat 
diet.
There was no difference in the level of inhibitory activity of NK 
cells from rats on a low fat or a high fat diet, when the RgTg tumor cell 
line was used as the target cell. The amount of inhibitory activity of 
the NK cells from rats on both diets was relatively low, compared to 
the response against YAC-1 tumor cells, but was not apparently due to 
the presence of NK cell-resistant tumor cells. The data suggested that 
the response against RgTg tumor cells was cytostatic, but not necessarily 
cytolytic.
Miile the ability of NK cells to inhibit proliferation of YAC-1 
tumor cells in vitro was diet dependent, the inability to show diet 
dependency on the ability of NK cells to inhibit the proliferation of 
the RgT^ tumor cells vitro did not necessar My rule out an in 
vivo role for NK cells in the resistance of rats to DMBA-induced tumors.
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APPENDIX
YAC-1 Tumor Cells 
The YAC-1 tumor cell line was used as one of the targets to assay 
for natural killer cell activity. Their original characteristics, and 
culture conditions were previously described in Materials and Methods. 
Studies indicated that cell cultures initiated with 5 x 10̂  cells/ml 
of viable, YAC-1 tumor cells, grew logarithmically for 48 hours, with 
an approximate doubling time of 24 hours. After 48 hours, the growth 
rate slowed, and no further increase in cell number was observed by 72 
hours. Viability of cells in logarithmic growth was consistently between 
97% and 100%, as measured by Trypan blue exclusion. To ensure that YAC-1 
cell targets maintained logarithmic growth, stock cultures were prepared 
each day, using an initial concentration of 5 x 10̂  cells/ml. These 
stock cultures were used 24 hours later at a concentration of 1 x 10̂  
cells/ml in the natural killer cell assays. In addition, 5 x 10̂  cells/ 
ml of YAC-1 tumor cells typically incorporated from 300,000 cpm to 
350,000 cpm after being cultured for 16 hours with an additional 3.5
3hour pulse of H-thymidine. This measurement served as an additional 
method to monitor whether or not the YAC-1 cells were in logarithmic 
growth on a daily basis.
RgTg Tumor Cells
The 2̂^2 tumor cell line was used as another source of target cell 
to assay for natural killer cell activity. Their origin, characteristics.
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and culture conditions were previously described in Materials and Methods. 
Studies indicated that 3 x 10̂  cells/ml of RgTg tumor cells represented 
a cell monolayer that was approximately 30% confluent in both microtiter 
test plate wells, and in T-75 tissue culture flasks. Doubling time of 
these cells was approximately 24 hours. Cell concentrations of 1 x 10̂  
cells/ml represented 100% confluent monolayers. Viability was consis­
tant ly between 96% and 100%, as measured by Trypan blue exclusion. To 
ensure that R^T^ tumor cells were provided with proper growth conditions 
for a 24 hour culture period, stock cultures were initiated with 3 x 10̂  
cells/ml, and were used 24 hours later to assay for natural killer cell 
activity. In addition, 3 x 10̂  cells/ml of RgTg tumor cells cultured
3for 16 hours, followed by an additional 3.5 hour incubation with H- 
thymidine, typically incorporated between 60,000 and 70,000 cpm. This 
method served as an additional way to determine whether or not the RgTg 
cells were in logarithmic growth on a daily basis.
Nonspecific Esterase Staining 
To determine the relative percentage of macrophages in unseparated 
and plastic beaded column separated spleen cell populations, spleen cell 
suspensions from rats on low fat or high fat diets, before and after 
column separation, were stained for nonspecific esterase, according to 
the method of Koski (59). Briefly, spleen cell suspensions were applied 
to slides that had been previously coated with fetal calf serum. The 
slides were then air dried and fixed in cold formaldehyde-acetone fix­
ative for 30 seconds. The slides were then incubated for 45 minutes at 
37°C in a solution of hexazotized pararosanaline and a-naphthyl butyrate.
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The slides were then washed with distilled water and counterstained with 
0.6% methyl green. Slides were examined under oil immersion. Cells 
containing nonspecific esterase were distinguished by the presence of 
multiple, intensely red stained granules in their cytoplasm, compared to 
the uniform green staining of nonspecific esterase negative cells. 
Approximately 200 cells were counted per preparation. Five animals from 
each diet were used for the evaluation. The results in Table 1 indicated 
that separation of spleen cells by plastic beaded columns reduced the 
number of esterase positive cells from 21.1% to 1.2% in animals on low 
fat diets, and from 22.3% to .9% in animals on high fat diets. There 
were no significant differences in the percentages of esterase positive 
cells removed by the plastic beaded columns between animals on the low 
fat or high fat diet.
Separation of Cells by Percoll Density Gradients 
Discontinuous Percoll density gradients were prepared in accordance 
with procedures previously described in Materials and Methods. Figure 1 
illustrates the composition of a typical gradient. Gradients were pre­
pared by pipetting 2 ml of each percentage Percoll solutions into 15 ml 
conical centrifuge tubes, starting with the highest percentage Percoll 
solution, followed by successive lower percentages. Discrete interfaces 
were formed between each percentage Percott solution. Spleen cells 
(3 X lo/) were carefully layered onto the top of each gradient, and the 
gradients centrifuged at 450 g for 30 minutes. The result was the for­
mation of distinct cell bands at each Percoll percentage interface.
Cells were collected from each interface by aspiration with a pipette 
and were assayed for natural killer cell activity. The use of density
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marker beads in a corresponding control tube established the density range 
of the gradient as being from 1,048 gm/ml to 1.087 gm/ml.
Optimization of Natural Killer Cell Assay (YAC-1)
Figure 2 illustrates an experiment in which various Percoll separ­
ated fractions of spleen cells were assayed for their ability to inhibit
3the H-thymidine incorporation of YAC-1 tumor cells. Whole spleen cell
populations and non-adherent cell populations (obtained by plastic
beaded column separation, see Materials and Methods) were used in this
study. Both spleen cell populations were separated by Percoll density
gradient centrifugation as described above. A volume of 0.1 ml of spleen
cells obtained from the different interface fractions of the Percoll
gradients was added to triplicate wells of microtiter test plates. In
addition, spleen cell populations not separated by Percoll were also
added to triplicate wells. The number of spleen cells added to tumor
cells was either 2 x 10̂  or 1 x 10̂ , yielding an effector (spleen cell)
to target (tumor cell) ratio of 2:1 and 1:1, respectively. Spleen cells
or tumor cells were also cultured alone. Spleen cells, tumor cells, and
spleen-tumor cell cultures at E:T ratios or 2:1 and 1:1 were incubated at
37°C for 16 hours in 10% CO2, followed by the addition of 1 yCi/well of 
3C H-6)-thymidine, and cultured for an additional 3.5 hours. The cell
3cultures were harvested, and the amount of H-thymidine incorporation
3determined (see Materials and Methods). The amount of H-thymidine in­
corporation of the YAC-1 tumor cell-spleen cell cultures was expressed
3as a percentage of the H-thymidine incorporation of the YAC-1 tumor 
cells cultured alone (control). The results were calculated using the 
following formula:
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3% of Control H-thymidine Incorporation =
(cpm of Spleen cells , (cpm of Spleen cells
+ YAC-1 cells) ™ cultured alone) ^
(cpm of YAC-1 cells cultured alone)
3Figure 2 illustrates that the H-thymidine incorporation by YAC-1 
calls was more inhibited by effector to target cell ratios of 2:1 com­
pared to ratios of 1:1. Non-adherent cells, either separated by Percoll, 
or used as unseparated (U) cells were more effective in inhibiting YAC-1
3H-thymidine incorporation than were whole spleen cell populations sub­
jected to the same separation procedures. All spleen cell fractions,
3however, inhibited the H-thymidine incorporation of YAC-1 cells to some
degree. The 55% and 60% Percoll fractions of spleen cells inhibited the
3H-thymidine incorporation of YAC-1 cells to the greatest degree. In 
all subsequent experiments, these two fractions were combined and desig­
nated as the NK cell fraction. Since non-adherent cells, separated by
3Percoll gradients, were more effective in inhibiting the H-thymidine 
incorporation compared to whole spleen cell populations separated by the 
same techniques, only non-adherent cells were used in all subsequent 
assays.
Figure 3 represents an experiment in which the 65%, NK, and (U) 
spleen cell populations were used to further optimize the natural killer 
cell assay, based on incubation time and E:T ratios. The E:T ratios of
16:1, 8:1, 4:1 and 2:1 were obtained by culturing 16 x 10̂ , 8 x 10̂ ,
5 5 54 X 10 , and 2 x 10 spleen cells with 1 x 10 YAC-1 tumor cells in the
wells of microtiter test plates. Spleen cells and tumor cells were also 
cultured alone. The incubation times were 3 hours, 6 hours, and 16 hours,
3with each incubation being followed by the addition of 1.0 yCi of ( H-b)-
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thymidine, and an additional 3.5 hour incubation, Cells were harvested
3and the H-thymidine incorporation determined (see Materials and Methods),
3Figure 3 demonstrates that maximum inhibition of H-thymidine incorpora­
tion of YAC-1 tumor cells occurred when NK cells were incubated with tar­
get cells for 16 hours at an E‘T ratio of 4:1 or greater. At E;T ratios 
of 8:1 and 16:1, the 65% and unseparated spleen cells also showed signifi­
cant inhibition at each of the three time points. Based on these results, 
NK cell activity against YAC-1 tumor cells was measured in all subsequent 
experiments, using an incubation time of 16 hours, with an E:T: ratio of 
4:1.
Optimization of Natural Killer Cell Assay (RgTg)
Figure 4 demonstrates an experiment designed to determine the opti­
mal E:T ratio when assaying for NK cell activity of the three spleen 
cell populations described above, against the RgTg cell line. The E:T
ratios of 13:1, 8:1, 4:1, and 2:1 were obtained by culturing 4 x 10̂ , --
2 X 10̂ , 1.3 X 10̂  and 6.5 x 10̂  spleen cells with 3 x 10̂  RgTg tumor 
cells in triplicate wells of microtiter test plates. Spleen cells and 
tumor cells were also cultured alone. The standard 16 hour incubation 
time was used so that results could be compared to previous experiments. 
After the initial incubation period, spleen cells and media were removed 
from the spleen cell-RgTg cultures, leaving the adherent RgTg tumor cells
3in the wells. All cultures were refed with media, and 1.0 yCi of ( H-6)- 
thymidine was added to each well. Cells were harvested, the RgTg tumor 
cells being removed by a 10 minute incubation with 0.25% trypsin contain-
3ing 0.02% EDTA, and the amount of H-thymidine incorporation determined
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3(see Materials and Methods). The amount of H-thymidine incorporation 
of the RgTg turaor-spleen cell cultures was expressed as a percentage of
3the H-thymidine incorporation of the RgTg tumor cells cultured alone 
(control). The results were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of spleen cells + R_T_ tumor cells)
--------------------------------------------LJl--------------------------- X 100
(cpm of RgTg cells cultured alone)
3The results indicated that maximum inhibition of H-thymidine 
incorporation occurred when NK cells were incubated with RgTg tumor cells 
at an E:T ratio of 13:1. The 65% and unseparated spleen cells also 
showed significant inhibition at this ratio. Based on these results, NK 
cell activity against RgTg tumor cells was measured in all subsequent 
experiments using an incubation time of 16 hours, and an E:T ratio of 
13:1.
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Table 1. Percent of nonspecific esterase positive spleen 
cells before and after plastic beaded column separation, from 




EFFECTS OF COLUMN SEPARATION ON THE PERCENT OF ESTERASE 
POSITIVE SPLEEN CELLS FROM RATS ON LOW OR HIGH FAT DIETS
BEFORE COLUMN A F T E R  C O L U M N
DIET DIET
LOW HIGH LOW HIGH
PERCENT OF CELLS 
STAINED POSITIVE 21.1 22.3 1.2 0.9
FOR NON-SPECIFIC +2.0 ±4,0 +.7 + .3
ESTERASE
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Figure,. 1. Discontinuous Percoll density gradient prepared by 
by pipetting different percentages of iso-osmotic Percoll solutions 
into a conical centrifuge tube. Spleen cells (.3 x 10̂ ) were added 
to the top of the 40% Percoll layer. The gradient was centrifuged 
at 450 G for 30 minutes. Spleen cells formed distinct bands at each 
Percoll density interface. Cells were collected by aspiration from each 
density band. Density of the gradient ranged from 1.048 gm.mi to 
1.087 gm.mi as determined by density marker beads.
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Figure 1.






3Figure 2. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
various Percoll separated and unseparated spleen cells at different effector to target cell ratios. 
Tumor cells, spleen cells, and tumor-spleen cell cultures were grown for 16 hours, followed by
3the addition of 1.0 uCi of H-thymidine and cultured for an additional 3.5 hours. Cells were
3 3harvested and the amount of H-thymidine incorporation determined. The H-thymidine incorporation
of the YAC-1 tumor cells cultured with the various spleen cell populations was expressed as a.;r>
3percentage of the H-thymidine incorporation of the YAC-1 tumor cells cultured alone (control).
The results were calculated using the following formula:
3 w% of Control H-thymidine Incorporation =
fcpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
-B Ai------A designates whole spleen cells used for Percoll separation.
D— —" —  -O A- —  —  —A  designates non-adherent cells used for Percoll deparation. 
U “ spleen cells not separated by Percoll.
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3Figure 3. Inhibition of incorporation of H-thymidine into YAC-1 tumor cells cultured with 
various Percoll separated and unseparatèd splèen cells for different periods of time;,and. 
different effector to target cell ratios. Tumor cells, spleen cells, and tumor-spleen cell
3cultures were grown for 3, 5, or 16 hours, followed by the addition of 1.0 uCi of H-thymidine,
3and cultured for an additional 3.5 hours. Cells were harvested, and the amount of H-thymidine
3incorporation determined. The H-thymidine incorporation of the YAC-1 tumor cells cultured with
3various fractions of spleen cells was expressed as a percentage of the H-thymidine incorporation 
of the YAC-1 tumor cells cultured alone (control). The results were calculated using the follow^.
I—»ing formula:
3% of Control H-thymidine Incorporation =■
(cpm of Spleen cells + YAC-1 cells) minus (cpm of Spleen cells cultured alone) X 100
(cpm of YAC-1 cells cultured alone)
HB designates 3 hours of growth. @------ ©designates 5 hours of growth. A—  —  — A
designates 16 hours of growth. U = spleen cells not separated by Percoll. NK = spleen cells 
obtained from the 55% and 60% fractions of Percoll. 65 = spleen cells obtained from the 65% 
fraction of Percoll.
% OF C O N T R O L  ^ H - T H Y M I D I N E  INCOR P O R AT I O N
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3Figure 4. Inhibition, of incorporation of H-thymidine into £̂'̂ 2 cells cultured with
various Percoll separated and unseparated spleen cells at different effector to target cell 
ratios. Tumor cells, spleen cells, and tumor-spleen cell cultures were grown for 16 hours,
3followed by removal of the spleen cells, and the addition of 1.0 uCi of H-thymidine to the 
tumor cell monolayers. These cells were incubated for an additional 3.5 hours, removed with 
trypsin:EDTA, and harvested. Inhibitory activity of each tumor-spleen cell culture was measured
3by determining the amount of H-thymidine incorporation of the R2"̂ 2 t"™°f"Spleen cell culture 
and expressing this as a percentage of the incorporation of the R,T„ tumor cells cultured alone
to(control). The results were calculated using the following formula:
3% of Control H-thymidine Incorporation =
(cpm of spleen cells + RJT_ tumor cells)
^  X 100
(cpm of R2^2 cells cultured alone)
Ü = spleen cells not separated by Percoll. NK = spleen cells obtained from the 55% and 60% 
fractions of Percoll. 65 = spleen cells obtained from the 65% fraction of Percoll.
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